Back to GetFilings.com



Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-K

(Mark One)

     
[X]   ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended February 28, 2003

OR

     
[  ]   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 0-14356

HEALTHTRAC, INC.

(Exact name of Registrant as specified in its charter)
     
Canada
(State or other jurisdiction of
incorporation or organization)
  911353658
(IRS Employer
Identification No.)
     
539 Middlefield Road, Redwood City, California
(Address of principal executive offices)
  94063
(Zip Code)

Registrant’s telephone number, including area code: (650) 839-5500

Securities registered pursuant to Section 12(b) of the Act:
None

Securities registered pursuant to Section 12(g) of the Act:
Common Stock

     Indicate by check mark whether the registrant (i) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (ii) has been subject to such filing requirements for the past 90 days. Yes [X] No [  ]

     Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. Yes [X] No [  ]

     Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Securities Exchange Act of 1934). Yes [  ] No [X]

     As of May 21, 2003, there were outstanding 223,104,598 shares of Common Stock of the registrant.

DOCUMENTS INCORPORATED BY REFERENCE

     Portions of the Registrant’s Proxy Statement to be submitted to the Commission on or before June 28, 2003, are incorporated by reference into Part III.

The Exhibit Index begins on page F-24.



 


TABLE OF CONTENTS

Item 1. Business
Item 2. Properties
Item 3. Legal Proceedings
Item 4. Submission of Matters to a Vote of Security Holders
PART II
Item 5. Market for Registrant’s Common Equity and Related Stockholder Matters
Item 6. Selected Financial Data
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 7B. Risk Factors
Item 8. Financial Statements and Supplementary Data
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
PART III
Item 10. Directors and Executive Officers of the Registrant
Item 11. Executive Compensation
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Item 13. Certain Relationships and Related Transactions
Item 14. Controls and Procedures
Item 15. Exhibits, Financial Statements, Schedules and Reports on Form 8-K
SIGNATURES
Exhibit Index
EXHIBIT 99.1


Table of Contents

INTRODUCTORY NOTE

     The Annual Report on Form 10-K contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and the Company intends that certain matters discussed in this report are “forward-looking statements” intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified by the context of the statement which may include words such as the Company “believes”, “anticipates”, “expects”, “forecasts”, “estimates”, or other words of similar meaning and context. Similarly, statements that describe future plans, objectives, outlooks, targets, models or goals are also deemed forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those forecasted or anticipated as of the date of this report. Certain of such risks and uncertainties are described in close proximity to such statements and elsewhere in this report, including Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations”. Stakeholders, potential investors and other readers are urged to consider these factors in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements or construe such statements to be a representation by the Company that the objectives or plans of the Company will be achieved. The forward-looking statements included in this report are made only as of the date of this report, and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

Item 1. Business

Available Information

     The Company maintains an Internet website at www.healthtrac.com which includes an investor relations page available to all interested parties, where links to recent filings with the United States Securities and Exchange Commission, along with any amendments to those reports are available free of charge, as reasonably practicable following the time they are filed with or furnished to the SEC.

General

     Our company was incorporated under the laws of the Province of British Columbia on January 29, 1982 under the name “Thunder Oil & Gas Ltd.”. Our name was changed to “Thunder Explorations Ltd.” on May 9, 1983. On April 22, 1985, we changed our name to “CAM-NET Communications Network Inc.” and on February 1, 1991, our company was continued under the Canada Business Corporations Act. On August 1, 1997, we changed our name to “Suncom Telecommunications, Inc.” and on May 31, 1999, we changed our name to “Virtualsellers.com, Inc.”. Following our Annual General and Special Meeting for the year ended February 28, 2001, on February 22, 2002, we changed our name to “Healthtrac, Inc.”.

     The Company is currently structured into two business units: Health Management, and Call Center Operations. Prior to September 23, 2002, the Company had a third business segment called the Professional Services and Software Products (PSSP) Group (formerly referred to as the e’commerce segment). In September 2002, management distributed the company’s information technology resources between its Greenwood, Indiana call center and Redwood City, California headquarters where the information technology staff has assumed responsibility for all of Healthtrac’s information technology products and services. Prior to February 28, 2002, the Company has a fourth business segment called Call Direct, a catalog telecommunication equipment resale business.

     The Company’s principal offices and subsidiaries are located in North America. Unless the context otherwise requires, the term “Company” refers to Healthtrac, Inc. and its subsidiaries.

Summary of Material Acquisitions During the Previous Five Years

NorthNet Telecommunications Inc. d/b/a “NorthStar Telesolutions”

     On January 1, 1998, we purchased our first call center for $105,000. As consideration for the acquisition, we issued a convertible note for $105,000 which was convertible into our common shares at the rate of $0.10 per common share. On January 5, 1999, the convertible note was converted into 1,050,000 of our common shares. The call center is operated through our subsidiary, NorthNet Telecommunications Inc. doing business as NorthStar Telesolutions. For details of the operations of our call center, see the section entitled “Call Center Operations” below.

1


Table of Contents

VirtualSellers.com, Inc.

     In April, 1999, we purchased certain assets and the business of VirtualSellers.com, Inc., an Illinois corporation. As consideration for the acquisition, we paid cash of $170,000, assumed indebtedness of US$28,929, issued 500,000 of our common shares and issued share purchase warrants to purchase up to 361,710 of our common shares. Each share purchase warrant entitled the holder to purchase one common share at a price of $1.50 per common share for a period of two years. As part of the acquisition, we entered into employment agreements with two of the founders of this company.

     Although we discontinued the operations of VirtualSellers.com, Inc. in fiscal 2002, we subsequently launched our Professional Services and Software Products (“PSSP”) which continued some of the services of VirtualSellers.com, Inc. The primary purpose of this Group was to market our TAME V software, provide the information technology services for our Healthtrac division and provide application development and Web-enabling solutions. This division was discontinued in fiscal 2003 and these operations are classified as discontinued operations in our annual financial statements filed under Item 8 of this Annual Report on Form 10-K.

CallDirect Enterprises Inc.

     In May, 1999, we purchased certain assets of CallDirect Enterprises Inc. As consideration for the acquisition, we issued 1,200,000 of our common shares and assumed the outstanding indebtedness of approximately CDN$500,000, which we settled for approximately CDN$109,000.

     On February 28, 2002, we announced that our subsidiary, Preferred Telemanagement Inc., doing business as CallDirect Enterprises, ceased operation on the last day of our fiscal year, February 28, 2002. As a result, we no longer operate as a catalogue reseller of telephone-related equipment, as well as of products such as multimedia, entertainment, travel, security and computer accessories for offices and homes. These operations are classified as discontinued operations in our annual financial statements filed under Item 8 of this Annual Report on Form 10-K.

TAME Software and Customer Base

     In June, 1999, we purchased the rights to a proprietary e-commerce shopping cart software system and language interpreter called TAME (Tag Activated Markup Enhancement) from Seth Russell and Nathan Bawden, doing business as Clickshop. As consideration for the acquisition, we assumed liabilities of $20,000 and issued 300,000 of our common shares (150,000 shares to each of Seth Russell and Nathan Bawden). As part of the acquisition, we entered into an employment agreement with Nathan Bawden. We also agreed to issue a further 300,000 of our common shares one year from closing if Nathan Bawden successfully trained our employees in the use, operation and development of TAME. These additional 300,000 shares were issued on February 13, 2001 (150,000 shares to each of Seth Russell and Nathan Bawden).

     For further details on TAME, see the section entitled “TAME (Tag Activated Markup Enhancement)” below.

Sullivan Park LLC

     On June 1, 2000, our subsidiary Sullivan Park Inc. acquired all of the assets of the Internet services development business carried on by Sullivan Park LLC in exchange for 6,500,000 of our common shares, which were issued to the owner, Edward Sharpless, on July 18, 2001. As part of the acquisition, our subsidiary Sullivan Park Inc. entered into an employment agreement with the former owner and retained several of its employees.

     The former owner of Sullivan Park, which was acquired by our company on June 1, 2000, had filed a claim against our company alleging that the company was in default of the terms of the purchase agreement. A counter claim was filed by the company, and on July 18, 2001 we reached a settlement and agreed to issue 6,500,000 common shares to the former owner of Sullivan Park. We also agreed to pay the former owner $8,885 to reimburse him for expenses he had incurred on our behalf.

     The operations of Sullivan Park were rolled into the company’s e-commerce division. On July 19, 2001, we discontinued the operations of Sullivan Park Inc. to focus our efforts and resources on our new health promotion business.

MedWired Corporation

     On April 20, 2001, we purchased certain assets of MedWired Corporation including the copyright, object code and source code for MedWired’s Practiceportal software, certain registered and unregistered trade or brand names, domain names and trademarks and MedWired’s customer list for a purchase price of $200,000 which we paid by issuing 241,935 of our common shares at an issue price of $0.62 per share (the fair market value of our stock at February 27, 2001) and $50,000 in cash. We abandoned these assets in fiscal 2003 to focus on our current programs.

2


Table of Contents

Healthscape, Inc.

     On June 26, 2001, we acquired Healthscape, Inc.’s proprietary software (and related intellectual property) for the sum of $245,000, $5,000 of which was paid in cash, with the balance paid in 631,579 shares of our common stock having a fair value of $0.38 per share. The Healthscape Expert System analyzes each user’s progress and the user health profile and provides tailored information to help each user meet their unique health goals. The Healthscape software, known as the Healthscape Expert System, is expandable to include new healthcare related applications and scalable to accommodate a growing user base. We abandoned these assets in fiscal 2003 to focus on our current programs.

Healthtrac, Inc.

     On August 3, 2001, our wholly-owned Nevada subsidiary, Healthtrac Corporation, acquired Healthtrac, Inc., a California corporation, pursuant to a Merger Agreement dated July 11, 2001. We acquired the shares of Healthtrac, Inc. in exchange for 13,529,412 common shares in the capital of our company. After we acquired all of the shares of Healthtrac, Inc., we merged it into Healthtrac Corporation as provided for in the Merger Agreement. As a result of the merger, we assumed a debt owed to a third party of $892,459, which we settled for $500,000 and paid in shares of our common stock at a price per share of $0.265. Also as a result of the merger, we obtained a loan for $110,000 at an interest rate of 1% over the Bank of America’s prime rate from Queensland Teachers Union Health Fund Limited. The loan is convertible at Queensland’s option into shares of our common stock on the date of maturity of the loan at a price that is equal to the price per share equal to the ten-day average closing price for the ten trading day period ending on the repayment date. Queensland also converted approximately $484,764 of debt owed it by Healthtrac, Inc. into shares of our common stock at a price of $0.265. Queensland also agreed to lend Healthtrac Corporation (the surviving corporation in the merger) money as needed over a period of nine months after the closing of the merger, for the purpose of purchasing books for resale to Healthtrac’s customers. The acquisition of Healthtrac, Inc. closed on August 3, 2001, although there are a number of post-closing obligations to be complied with, including the issuance of 316,436 of the total of 13,529,412 common shares that we agreed to issue in the exchange, which will be issued upon the submission to us by some of the shareholders of Healthtrac, Inc., of certain paperwork still required of them pursuant to the merger agreement.

     For further details on the operations of our health promotion division, see the section entitled “Health Promotion Management” below.

Health Management Operations

     Healthtrac Corp. provides health management services to health plans, self-insured employers and government agencies via programs designed to postpone disease and disability through preventive practices and chronic disease self-management. Our health risk assessment identifies high-risk constituents prior to high claims utilization, our tailored interventions reduce health risks and costs by supporting healthy changes and condition management, and our reporting capabilities track changes over time and evaluate each program’s impact. Healthtrac measures return on investment, participant and group changes in health risks, health consumerism, and productivity, and tracks reductions in healthcare usage.

     Healthtrac’s products and services are designed to enhance the quality of care while reducing the overall cost of health care. Our programs are intended to not only lead the way to better health but to do so in a way that can be continually measured in terms of effectiveness and results.

     The fundamental mission of Healthtrac#to improve the health status of the population#is reflected in all of our programs. Our goals are to reduce health risks and improve health status, reduce health care costs, and provide sound data on program impact.

     Healthtrac offers a variety of programs ranging from minimal intervention (Healthtrac Premier) for the entire client population, to intensive interventions for those at greatest risk (Healthtrac Enhanced). Our products are available to participants through the mail or via the Internet.

     The core components of the Healthtrac programs are:

    Health Assessments (i.e. the tool used to measure and monitor the population’s health risks, and to identify those individuals at greatest risk for poor health status);

3


Table of Contents

    Self-Care (e.g. Take Care of Yourself book versions, health promotion newsletter, self-care books, online medical encyclopedia, medical Libraries, health news and content);
 
    Health Education and Promotion (e.g. health education materials, personalized letters and reports summarizing health assessment responses and providing encouragement to take action to improve health, online Learning Centers)
 
    High Risk Identification and Intervention (e.g., targeted risk and condition-specific health education materials and health education telephone counseling).

     Healthtrac Premier reduces the need and demand for health care services by helping participants increase their personal health self-confidence and their ability to employ effective self-management practices. This program provides essential health promotion intervention to participants through universal health information, education, and support to help participants achieve and maintain the highest possible level of well-being. Tailored and targeted feedback reinforces healthy changes based on their self-efficacy and readiness to make changes, wherever they may be on the health continuum. The results are reinforcement of gradual progress toward goals, improvements in health status and reductions in health risks, accompanied by a decrease in unnecessary and inappropriate use of medical care resources.

     The Healthtrac Enhanced program provides an intensive health education intervention for those who are at greatest risk to utilize high cost services. Effective interventions targeted to this high cost population can yield substantial savings. With proactive, early intervention, what might otherwise become major medical problems, with associated expenses, absenteeism and loss of productivity, can be minimized or, in some cases, completely avoided. As evidence of the effectiveness of this approach, the Healthtrac High Risk program yields ROI’s as high as 8:1, as proven through published research.

     There are twelve risk modules in the High Risk Program, more being developed in 2003, each emphasizing a specific lifestyle-related or chronic condition.

     The lifestyle risk modules are:

     
•       Cigarette smoking   •       Overweight
•       Stress   •       Combined lifestyle risks: high stress, sedentary lifestyle, poor
        nutrition

     The chronic condition modules are:

     
•       Arthritis   •       Asthma
•       Back Pain   •       Diabetes
•       Heart Disease   •       High Blood Pressure
•       Lung/Respiratory Disease   •       Stroke

Our supporting services include:

    Client Services (e.g. assists with the day-to-day management of the program)
 
    Account Management (e.g. consults with the client to determine strategic needs and meet objectives)
 
    Medical Consultation (e.g. James Fries, MD, Medical Director for Healthtrac provides demand management, research, and other consultation for clients)
 
    Health Education Consultation (e.g. our health educators provide consultation on health promotion programs and educational materials)
 
    Claims Analysis (e.g. evaluation and comparison of healthcare, workers compensation, disability claims, and personnel measures with Healthtrac data).
 
    Call Center Counseling (e.g. health decision support-24 hours a day, seven days a week)

4


Table of Contents

     All Healthtrac programs employ four essential strategies:

  1.   Analysis of the participant’s health status through health assessment questionnaires
 
  2.   Development of a personal action plan#tailored to the individual’s needs and readiness to change#that is designed to increase self-efficacy and reduce health risks
 
  3.   Education in wise and appropriate medical care decision-making
 
  4.   Ongoing reinforcement of positive health habit changes through periodic health assessment, serial tracking of changes in health status and health risks, and targeted health promotion messages

Healthtrac’s Customers

     The majority of Healthtrac clients are self-funded employer groups, health plans/managed care organizations, hospital systems, and the military. Healthtrac generally has long-term relationships and long-term contracts with its clients. Many are in the process of renewing their agreements with Healthtrac. We target businesses that have an eligible base of 5,000 or more.

Distribution

     Healthtrac’s products and services have traditionally been delivered via paper/manual delivery, but Healthtrac now has its programs available over the Internet through its personal health portal, MyHealthtrac.com. Healthtrac distributes its products and services in the following manner: Healthtrac contracts with an organization, (e.g. a self-insured employer), to provide a health promotion program to the employer’s employees or the health plan’s members. Of the total eligible participants, a percentage of the employees or members become actual Healthtrac program participants. Healthtrac enrolls these participants into our proprietary system and then generates the initial health risk assessment for each participant. The participant completes the assessment, returns it to Healthtrac, and then Healthtrac analyzes the assessment using its predictive algorithms. Healthtrac then generates a letter and report uniquely tailored to each individual, addressing that individual’s health status and risks. Based on the findings of the analysis, the individual is either enrolled in a high risk program or placed in the basic or low risk, program. The participant then receives ongoing health information, educational materials, and self management tools (interventions) tailored to the individual’s health maintenance or improvement goals. The participants are then reassessed at periodic intervals. Healthtrac is exceptional in its market because of this “serial tracking” of its participants. This serial tracking reports the individual’s successes and progress toward meeting their health improvement goals over time. Healthtrac also provides aggregate reports to its clients to measure the program’s success.

     Healthtrac’s products and services were initially developed in 1984 when Healthtrac was founded. Healthtrac continually evaluates its health assessment tool to incorporate the most current (accepted and valid) scientific, medical, demand management, and lifestyle behavior change concepts. This requires ongoing design/redesign, testing, and monitoring of the questionnaire responses and the associated algorithms used to calculate risk scores and health status. We also encourage feedback from our clients’ medical teams.

     Development of our online health risk assessment is complete and we have already sold this product to our first client. A static version and tour of the online questionnaire and ancillary products is available for viewing through our sales group.

Industry Overview

     If the health of American citizens were improved, logic indicates we would spend less time and money treating the many diseases that are clearly preventable.

There is ample evidence that poor health habits cost dearly: By way of example:

  -   preventable illness makes up approximately 70 percent of the burden of illness and the associated costs. Well-developed national statistics such as those outlined in Healthy People 2000 (2010) document this central fact clearly. McGinnis and Foege have carefully reclassified the causes of death in the United States, using underlying actual causes rather than the traditional disease-oriented classifications; they found that preventable causes account for eight of the nine leading categories and for 980,000 deaths per year. (J. F. Fries, et.al. New England Journal of Medicine 1993; 329:321-325; and J.M. McGinnis, W. H. Foege, Journal of American Medical Association 1993; Volume 270, No. 18).
 
  -   the U.S. Congress Office of Technology Assessment estimated that, in 1985, smokers cost businesses $43 billion in lost earnings. (OTA, US Congress. Smoking-related Deaths and Financial Costs. Washington, DC: Health Program, OTA; 1985 OTA staff memorandum).

5


Table of Contents

  -   obesity in the US accounts for approximately 5% of all health care costs (Thompson, D., Edelsberg, J., Kinsey, K. L., Oster, G. Estimated economic costs of obesity of US business. Am J Health Promotion. 1998; 13:120-127.)
 
  -   current medical research, according to Nutritional Health Magazine (11/2001), shows that 50% of the American population is overweight.
 
  -   employees with six heart disease risk factors had future medical costs 149% higher than those with no risk factors. Those with three stroke risk factors had costs 52% higher than those without the same risk factors. (Jee S, O’Donnell M, Suh I, Kim I. The relationship between modifiable health risks and future medical expenditures: the Korea Medical Insurance Corporation employee study. Am J. Health Promotion. 2001; 15: 244-255).

     Today, there is an expanding demographic looking for new methods of increasing their well being through health promotion and disease management products. For individuals following a health promotion program or maintaining a healthy lifestyle, the results can be very dramatic: the individual is likely to have more energy, fewer physical problems, greater mental alertness, greater athletic prowess, feel better, look younger, and be healthier than his or her peers who did not adopt healthy living practices. For those individuals following an unhealthy lifestyle, the results can be just as dramatic: increased illness and disease, frequent absenteeism, prolonged disability, and early death.

     Interest in worksite health promotion has grown steadily since the mid-1980s when employers became concerned about rapidly rising health care costs. Employers, managed care providers and third party administrators all share the following needs:

  - to manage and control participant health benefit costs;
- - to decrease demand for unnecessary or avoidable healthcare services;
- - to build participant satisfaction and increase productivity;
- - to re-connect and focus on the participant as the primary stakeholder in healthcare;
- - to empower, educate, inform, and guide participants to better health;
- - to secure best of breed, best in class to affect the health and well being of participants;
- - to improve health status of their participants;
- - to reduce and/or stabilize the risks in their participants’ lives; and
- - to achieve a return on investment.

Competition

     Generally speaking, Healthtrac competes in the health promotion and wellness market in which over 20 companies provide health promotion services with primary emphasis on health risk assessments, lifestyle, and behavioural modification and condition specific personal care management. Of these, the Mayo clinic, Wellmed, Staywell, Johnson & Johnson, and WebMD constitute Healthtrac’s competitors. This statement is biased towards health assessments as a core service and the ancillary non-core services that enhance the overall value proposition as it relates to overall health management. Each of these companies possesses unique strengths and weaknesses in delivery of health assessment technologies. We estimate that these five companies combined boast over 2300 current individual group clients and make up the critical mass of the marketplace.

     Healthtrac has over 18 years of experience providing comprehensive health assessment, health promotion, and self-care products and services in the United States and internationally. More than one million individuals have used the Healthtrac health assessment instrument and over three million health assessment questionnaires have been completed, making it one of the most highly used and tested questionnaires in the industry.

     Our health assessment and associated health promotion programs have been studied more extensively than any other such programs. Numerous studies, published in peer-reviewed medical and scientific literature, have found the health assessment and its educational programs to be highly effective in motivating positive change in health habits, resulting in lower risks and measurable reductions in the use of unnecessary, inappropriate and costly health care services.

     Healthtrac has won numerous awards over the years, and is the only six-time winner of the C. Everett Koop National Health Award that recognizes programs that are proven to reduce health risks and health care costs.

     Prior to our acquisition of Healthtrac in 2001, it had languished with few resources directed toward marketing, sales, and technology. We are rebuilding our sales and marketing efforts, reestablishing our visibility in the marketplace, and improving our technology platform. During the fiscal year ended February 28, 2002, Healthtrac

6


Table of Contents

expanded its marketing and sales efforts in an effort to increase its visibility in the market. We have increased our sales force in an effort to fully service our existing clients and to capture new clients. Healthtrac continues to pursue alliances with strategic sales partners to expand the market penetration of our products and services. Healthtrac is also focused on renewing existing client contracts and selling additional and enhanced products to our existing clients. In addition, Healthtrac completed the migration to our new software platform, the Windows NT/TAME platform, thus vastly improving our technology.

     Health Insurance Portability and Accountability Act of 1996

     The US Congress enacted the Health Insurance Portability and Accountability Act of 1996 (HIPAA), including Standards for Privacy of Individually Identifiable Health Information. The law included provisions designed to save money for health care businesses by encouraging electronic transactions, but also required new safeguards to protect the security and confidentiality of that information. Most states already have similar laws, but HIPAA ensured the closing of gaps in the protection of patients’ privacy and confidentiality.

     The privacy standards rule applies to our Healthtrac business because Healthtrac relates to participants in the healthcare industry. We believe that Healthtrac is a business associate under the HIPAA privacy standards rule. Therefore, we will provide satisfactory assurances to our clients who must comply with HIPAA that we will use its participants’ personal health information only for the purpose for which we were engaged by the client. In addition, we have developed our own privacy policy which assures our clients and our individual users that their information will remain confidential.

Call Center Operations

     We operate one call center through our subsidiary, NorthNet Telecommunications, Inc. doing business as NorthStar TeleSolutions. Our call center is located at 125 Airport Parkway, Greenwood, Indiana. Our call center provides back office services such as outbound and inbound customer support, centralized customer billing, customer sales and support, order entry, order fulfillment, bill collection, IT help desk support, as well as management reporting, database management, service scheduling and dispatch, marketing services and remote service maintenance. Our call center currently has the capacity for over 80 call center representatives and offers customer service support 24-hours a day, seven days a week. We provide our services for a flat monthly rate or on a per-transaction basis depending on the scope of services required.

     In the past, we have provided services to a limited number of cable television operators and Internet service providers in the United States. Even though we have recently lost some small clients primarily due to economic conditions, we have expanded our client base and now service over 60,000 homes with cable television and/or other broadband services. We target businesses that have a customer base of up to 20,000 customers, as we have found that businesses with more than 20,000 customers typically have well established in-house call centers. We market our call center services through periodic advertising, direct mail, strategic partnerships and outbound telemarketing, as well as by appearances at industry trade-shows.

     We concentrate our call center services on customer support and transaction processing, allowing our clients to concentrate on the marketing and growth of their businesses while still maintaining a high level of customer care and service. We are cultivating new customers for the call center, which have also begun to provide cable-related services such as local and long distance telecommunications and Internet access. By utilizing our service we are able to bundle and/or market together the services provided by our clients. We have also had quite a bit of success with our newest service that enables us to remotely control the services of our client’s subscribers. This service greatly reduces the operating cost to our clients by eliminating truck rolls while improving customer satisfaction as they are able to receive immediate service and enhanced service offerings.

     We are continuing to expand our scope of service that we provide. In the past, we provided limited services to cable television operators and Internet service providers in the United States. We have expanded the scope of our call center operations and are better positioned to support new and existing clients that offer the latest services and technologies. We currently handle approximately 45,000 transactions and 16,000 calls per month and have the resources to significantly increase each of these.

7


Table of Contents

Discontinued Operations

     In fiscal 2002, the Company discontinued its telecommunications catalogue resale business which was located in British Columbia, Canada. The division was closed and the Company did not realize any proceeds on disposition.

     In fiscal 2003, the Company discontinued its e-commerce division that had been substantially curtailed in fiscal 2002 as a result of cash flow and profitability concerns. The division was closed and the Company did not realize any proceeds on disposition in 2002 or 2003. Previously, the e’commerce division operated an internet shopping cart website whereby customers could purchase products for sale by the Company, and performed consulting services related to website design, development projects and hosting services.

Employees

     As of February 28, 2003, the Company employs approximately 37 full-time employees. All employees are located in the United States. The Company believes that its employee relations are excellent. The employees and the Company are not parties to any collective bargaining agreements.

Recent Developments

     In May 2003, the Company rolled out www.myhealthtrac.com to its first online client. The new portal allows program participants to complete their health risks assessments and receive real time feedback. In addition, participants can read comprehensive health materials and track their progress..

Item 2. Properties

     The Company’s executive offices and principal facility are located in an approximately 3,729 square foot building in Redwood City, California. The Company leases the facility pursuant to a lease expiring October 2006.

     The Company leases a facility in Greenwood, Indiana, that is used as a call center and operations support facility. The lease is for approximately 8,446 square feet. The lease expires in July 2006.

Item 3. Legal Proceedings

     On September 25, 2001, Rolling Meadows Associates, I, LLC, by Zaragon Holdings, Inc., filed a Complaint in Cook County, Illinois Circuit Court against VirtualSellers.com, Inc. for possession of the premises located at 3075 Tollview Drive, Rolling Meadows Illinois and for rent or damages for withholding possession of these premises for the period from September 1, 2001 through September 30, 2001 in the amount of $26,315 plus all rents accruing through the date of trial. A complaint was filed for rent and damages in the amount of $859,512. The Company’s position on this proceeding is that the building has been sublet and deny that they owe the Plaintiff any money. The outcome of this complaint is currently uncertain and consequently no amounts have been accrued as at November 30, 2002. Management is in current discussions with the plaintiff to settle the dispute.

     On July 25, 2001 in the Vancouver Registry of the Supreme Court of British Columbia, our company commenced a lawsuit against Telemetrix Solutions Inc. (formerly Telemetrix Resource Group, Inc.) and Tracy Corporation II dba Western Total Communications asserting a claim against Telemetrix and Tracy in the amount of CDN$64,658 jointly and severally (plus pre-judgment interest) pursuant to a letter agreement entered into between the parties on or about July 14, 1998 with respect to a possible business combination between the parties which was never completed. A provision in the agreement regarding the proposed business combination obligated Telemetrix and Tracy to pay our costs in connection with the proposed business combination. Although no Appearance or Statement of Defense has been filed on behalf of Telemetrix and Tracy, they have advised us that they take the position that the British Columbia Court has no jurisdiction over this matter and further, that any dispute must be dealt with by way of arbitration to be held in Denver, Colorado.

     On October 18, 2001, Steven & Marc Holdings, Inc. filed a lawsuit against our company in the Supreme Court of the State of New York, Court of New York, Case No. 604972/01. In this lawsuit, Steven & Marc Holdings, Inc., a public relations firm, is claiming that we owe them $61,480, plus interest and costs, for services rendered but not paid for between March and October of 2001. We have filed an Answer in this lawsuit and we are attempting to settle it at a reduced amount on a payment plan. The company is currently in discussion with the Plaintiff to settle the lawsuit.

     The Company is also involved in other legal proceedings and claims arising in the ordinary course of business. The Company does not believe that any liabilities related to the legal proceedings to which it is a party are likely to be, individually or in the aggregate, material to the Company’s consolidated financial condition, results of operations or cash flows.

8


Table of Contents

Item 4. Submission of Matters to a Vote of Security Holders

     Neither the Board of Directors, nor any security holder, submitted any matter during the fourth quarter of the fiscal year covered by this Report to a vote of the security holders through solicitation of proxies or otherwise.

PART II

Item 5. Market for Registrant’s Common Equity and Related Stockholder Matters

     The Common Stock of the Company is traded on the OTC Bulletin Board under the symbol “HTAC.” The following table sets forth high and low “sales” prices of the shares of Common Stock of the Company for the periods indicated (as reported by the National Quotation Bureau).

                   
      High   Low
     
 
2003:
               
 
First Quarter
    0.18       0.08  
 
Second Quarter
    0.09       0.04  
 
Third Quarter
    0.08       0.02  
 
Fourth Quarter
    0.05       0.01  
2002:
               
 
First Quarter
    0.69       0.28  
 
Second Quarter
    0.42       0.20  
 
Third Quarter
    0.20       0.07  
 
Fourth Quarter
    0.29       0.08  

     On May 1, 2002, the shareholders’ list for our common shares showed 2,251 registered shareholders (42 residents of Canada holding 11,180,336 common shares; 2,202 residents of the United States holding 189,493,325 common shares; and 7 residents of other countries holding 5,699,638 common shares), and a total of 207,373,299 common shares outstanding.

     The Company has never paid cash dividends on its Common Stock and the Board of Directors intends to retain all of its earnings, if any, to finance the development and expansion of its business. However, there can be no assurance that the Company can successfully expand its operations or that such expansion will prove profitable. Future dividend policy will depend upon the Company’s earnings, capital requirements, financial condition and other factors considered relevant by the Company’s Board of Directors.

9


Table of Contents

Item 6. Selected Financial Data

     The following selected historical financial data has been derived from the audited consolidated financial statements of the Company. This information should be read in conjunction with the Company’s Consolidated Financial Statements and the Notes thereto as well as “Management’s Discussion and Analysis of Financial Condition and Results of Operations”, included in Item 7. In the fourth quarter of 2002, the Company discontinued CallDirect and closed its facility in British Columbia, Canada. In the third quarter of 2003, the Company discontinued the e’commerce division and closed its facility in Chicago, Illinois. CallDirect and the e’commerce division’s results of operations are included in the income (loss) from discontinued operations (see Note 5 to Notes to Consolidated Financial Statements). All prior year information has been adjusted to conform to 2003 presentation.

                                             
        Years Ended February 28, 2003,
       
        2003   2002   2001   2000   1999
       
 
 
 
 
                (in thousands, except per share amounts)        
Selected Consolidated Statement of Operations Data:
                                       
 
Net sales
  $ 3,604     $ 2,780     $ 770     $ 333     $ 17  
 
Income (loss) from continuing operations
  $ (2,165 )   $ (3,642 )   $ 2,842     $ (3,081 )   $ (1,595 )
 
Loss from discontinued operations
    4       (6,275 )     (3,869 )     (1,612 )      
 
   
     
     
     
     
 
 
Net income (loss)
  $ (2,161 )   $ (9,917 )   $ (6,711 )   $ (4,693 )   $ (1,595 )
 
   
     
     
     
     
 
 
Basic income (loss) per share:
                                       
   
Continuing operations
  $ (0.01 )   $ (0.02 )   $ (0.02 )   $ (0.03 )   $ (0.02 )
   
Discontinued operations
    (0.00 )     (0.04       (0.03 )     (0.02 )      
 
   
     
     
     
     
 
   
Net income (loss)
  $ (0.01 )   $ (0.06 )   $ (0.05 )   $ (0.05 )   $ (0.02 )
 
   
     
     
     
     
 
 
Diluted income (loss) per share:
                                       
   
Continuing operations
  $ (0.01 )   $ (0.02 )   $ (0.02 )   $ (0.03 )   $ (0.02 )
   
Discontinued operations
    (0.00 )     (0.04 )     (0.03 )     (0.02 )      
 
   
     
     
     
     
 
   
Net income (loss)
  $ (0.01 )   $ (0.06 )   $ (0.05 )   $ (0.05 )   $ (0.02 )
 
   
     
     
     
     
 
 
Shares used in calculating net income (loss) per share:
                                       
   
Basic
    214,797       154,543       126,934       91,557       65,748  
   
Diluted
    214,797       154,543       126,934       91,557       65,748  
Selected Consolidated Balance Sheet Data:
                                       
 
Total assets
  $ 5,164     $ 7,209     $ 6,268     $ 2,740     $ 218  
 
Long-term debt, net of current portion
    9       23                    


    See Management’s Discussion and Analysis and Notes to Consolidated Financial Statements for information relating to significant items affecting the results of operations.

10


Table of Contents

Item 7A. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     The following is management’s discussion and analysis of certain significant factors that have affected the profitability of the Company’s business segments from its continuing operations and its consolidated results of operations and financial condition during the periods included in the accompanying consolidated financial statements. The following should be read in conjunction with the consolidated financial statements and related notes.

Critical Accounting Policies and Estimates

     The Company’s financial statements are based on the selection and application of significant accounting policies, which require management to make significant estimates and assumptions. The Company believes that the following are some of the more critical judgment areas in the application of its accounting policies that currently affect its consolidated financial condition and results of operations.

Revenue Recognition

     Healthtrac recognizes revenues from product sales at the time of shipment. On long-term contracts, Healthtrac recognizes revenue and profit as work progresses using the percentage-of-completion method, which relies on estimates of total expected contract revenue and costs. For Other program fees (postage, printing, books, data file distribution, etc.), revenues are recognized at the time of billing.

Accounts Receivable

     The Company is required to estimate the collectibility of its trade receivables and unbilled costs and fees. A considerable amount of judgment is required in assessing the ultimate realization of these receivables including the current credit-worthiness of each customer.

Inventory

     The Company is required to state its inventories at the lower of cost or market. In assessing the ultimate realization of inventories, the Company is required to exercise judgment in its assessment of future demand requirements and compare that with the current or committed inventory levels. The Company recorded charges for required reserves in the fiscal years 2003 and 2002 due to changes in strategic direction and market conditions. It is possible that changes in required inventory reserves may continue to occur in the future due to market conditions.

Capitalized Software Development Costs

     The Company’s policy on capitalized software costs determines the timing of recognition of certain development costs. In addition, this policy determines whether the cost is classified as development expense or cost of license fees. Management is required to use professional judgment in determining whether development costs meet the criteria for immediate expense or capitalization.

     Statement of Financial Accounting Standards (SFAS) No. 86, “Accounting for the Costs of Computer Software to be Sold, Leased or Otherwise Marketed,” requires capitalization of certain software development costs subsequent to the establishment of technological feasibility. Based upon the Company’s product development process, technological feasibility is established upon completion of a working model. Amortization of capitalized software development costs commences when the products are available for general release to customers and is determined using the straight-line method over the expected useful lives of the respective products. Software

11


Table of Contents

development costs are written-off when projects are abandoned or when the estimated cash flows from a product are not expected to be sufficient to recover the capitalized software development costs.

Outlook

     Our ability to continue as a going concern and to realize the carrying value of our assets is dependent on our ability to obtain additional financing to fund future operations and on our ability to translate our growth into profitable operations. The outcome of these matters cannot be predicted with any certainty at this time. Accordingly, our consolidated financial statements contain note disclosures describing the circumstances that lead there to be doubt over our ability to continue as a going concern. In their report on the annual consolidated financial statements for the year-ended February 28, 2003, our independent auditors included an explanatory paragraph regarding our ability to continue as a going concern. The consolidated financial statements included in this annual report have been prepared without any adjustments that would be necessary if we become unable to continue as a going concern and therefore required to realize upon our assets and discharge our liabilities in other than the normal course of operations.

FISCAL YEAR 2003 COMPARED TO FISCAL YEAR 2002

     On a consolidated basis, revenues from continuing operations for the year ended February 28, 2003 (“fiscal 2003”) were $3,604,433 an increase of $823,961 or 30% from the revenues of $2,780,472 reported for the year ended February 28, 2002 (“fiscal 2002”). The increase in revenues is primarily due to the addition of our new Healthtrac population health management division in August 2001, which recognized revenues of $3,604,433.

     NorthStar revenue increased $19,983 to $1,249,802 for fiscal 2003 compared to $1,229,819 for fiscal 2002. The Call Center generates revenue by providing transaction processing and backroom services including inbound and outbound telemarketing, customer and technical support, customer order entry, centralized billing and collection, order fulfillment, customer dispatch functions and other related services.

     Consolidated selling, general and administrative expenses from continuing operations decreased to $3,580,063 from $5,146,813 in fiscal 2002, an decrease of $1,566,750. Wages and benefits represent 51% (30% in fiscal 2002) of these costs. Wages and benefits increased by $270,398 due primarily to the addition of Healthtrac. An decrease in accounting and legal expense of $332,436 due to cost containment initiatives and conclusion of various lawsuits brought by and against our company, an decrease in consulting fees of $726,137 due to the issuance of non-cash share compensation paid to Healthtrac consultants of $450,000 in fiscal 2002.

     Direct product costs have increased to $663,894 in fiscal 2003 from $534,753 in fiscal 2002. Direct product costs relate to the product sold by Healthtrac to support its population health management business.

     Depreciation and amortization increased from $843,856 in fiscal 2002 to $1,393,988 in fiscal 2003, an increase of $550,132 or 65%. This increase is a result of the significant capital purchases, primarily related to the Healthtrac acquisition.

     For fiscal 2003, our company recognized a loss of $2,161,235 or $0.01 per share, compared to a loss of $9,916,809 or $0.06 per share for fiscal 2002. This loss is a result of the factors discussed above.

12


Table of Contents

FISCAL YEAR 2002 COMPARED TO FISCAL YEAR 2001

     On a consolidated basis, revenues from continuing operations for the year ended February 28, 2002 (“fiscal 2002”) were $2,780,472 an increase of $2,01,032 or 261% from the revenues of $770,153 reported for the year ended February 28, 2001 (“fiscal 2001”). The increase in revenues is primarily due to the addition of our new Healthtrac population health management division, which produced revenues of $1,550,653.

     NorthStar revenue increased $459,666 to $1,229,819 for fiscal 2002 compared to $770,153 for fiscal 2001. The Call Center generates revenue by providing transaction processing and backroom services including inbound and outbound telemarketing, customer and technical support, customer order entry, centralized billing and collection, order fulfillment, customer dispatch functions and other related services. The increase in revenues from the prior year is attributable to the signing of additional contracts in the fiscal year which resulted in an increase in the number of cable service customers.

     Consolidated selling, general and administrative expenses from continuing operations increased to $5,146,813 from $3,580,063 in fiscal 2001, an increase of $566,750. Wages and benefits represent 30% (31% in fiscal 2001) of these costs. Wages and benefits increased by $445,850 due primarily to the addition of Healthtrac. In the prior year, a significant portion of the compensation was paid through the issuance of shares to our officers and directors. An increase in accounting and legal expense of $338,610 due to various lawsuits brought by and against our company, an increase in consulting fees of $734,385 due to non-cash share compensation paid to Healthtrac consultants of $450,000 and increases in travel and promotion of $99,579 due to the acquisition of Healthtrac, whose offices are located in Redwood City, California. Corporate general and administrative expenses decreased to $2,068,132 from $2,714,560. This decrease is due primarily to the decrease in non-cash compensation paid to officers and directions of our company.

     Direct product costs have increased to $534,753 in fiscal 2002 from $0 in fiscal 2001. Direct product costs of $534,753 relate to the product sold by the population health management business.

     The Call Center’s selling, general and administrative expenses have increased to $1,386,035 compared to $908,953 in the prior year. This represents an increase of 53% whereas revenue from the segment increased 60%. The Call Center’s primary costs continue to be payroll, telephone, rent, printing, postage and office costs.

     Depreciation and amortization increased from $36,941 in fiscal 2001 to $843,856 in fiscal 2002, an increase of $806,915. This increase is a result of the significant capital purchases, primarily related to the Healthtrac acquisition.

     We curtailed our e-commerce operations in fiscal 2002 due to the decline in the business of technology and internet companies and the shift in focus towards the health promotion and disease management business. Our Sullivan Park operations and transaction processing services were closed and the remaining services curtailed. As a result, we wrote-off the remaining goodwill acquired on the Sullivan Park acquisition of $1,522,758 and we wrote-down our e-commerce equipment by $1,330,000 to its estimated net realizable value of approximately $160,000.

13


Table of Contents

     We recovered $104,980 from a former customer as a result of settlement of litigation that commenced in prior years. Other income (expense) changed from an income of $118,706 in fiscal 2001 to $6,284 in fiscal 2002, primarily the result of lower interest income as cash balances declined during the year.

     On February 28, 2002, we discontinued our CallDirect catalogue business. The CallDirect business earned revenue of $210,443 and had a loss of $170,639 for fiscal 2002 compared to revenue of $327,935 and a loss of $272,774 for fiscal 2001.

     For fiscal 2002, our company recognized a loss of $9,916,809 or $0.06 per share, compared to a loss of $6,711,117 or $0.05 per share for fiscal 2001. This loss is a result of the factors discussed above.

Liquidity and Capital Resources

     As at February 28, 2003, the company had a net working capital deficiency of $1,618,647, capital assets with a book value of $169,994, intellectual property with a book value of $4,133,359 and obligations under capital leases of $9,344 resulting in a net equity of $4,124,015.

     During fiscal 2003, we used $271,533 in cash to fund operations compared to $3,059,285 in fiscal 2002. We used $36,060 to fund investing activities which consisted primarily of capital asset additions. Cash of $210,807 was obtained during the year from financing activities for a net decrease in cash of $96,786. Cash at February 28, 2003 was $186,873.

     We have historically funded operations through the issuance of common shares. We expect the need to fund our working capital deficit, future operations and investments through the issuance of common shares. Subsequent to February 28, 2003, there have not been any sales of common shares.

     We estimate our cash requirements for capital asset additions and for operations for fiscal 2004 to be less than $500,000. We will continue to search for appropriate acquisitions to compliment our existing operations. Where possible, we will pay for acquisitions through the issuance of our common shares.

Item 7B. Risk Factors

     An investment in our securities involves significant risks, including those described below. These risks relate to our business model, our ability to generate revenues and gain operating efficiencies, our history of losses, significant changes, our ability to hire and retain key personnel, our reliance on technology providers and internal technology applications, the possible delisting of our common stock, and legal claims against us.

     Our actual results may differ materially from those expressed in any forward-looking statement as a result of certain factors, including but not limited to those set forth below and included in other portions of this document.

Foreign Exchange Rate Risk

     The Company operates internationally and has adopted local currencies as the functional currencies for its foreign subsidiaries because their principal economic activities are most closely tied to the respective local currencies. This exposes the Company to market risk from changes in foreign exchange rates to the extent that transactions are not denominated in the U.S. dollar. In consolidation, the Company converts the accounts of its foreign subsidiaries from the functional currency to the U.S. dollar. As a result, the Company faces the risk that the foreign currencies will have declined in value as compared to the U.S. dollar, resulting in a foreign currency translation loss.

Most Of Our Agreements Are Short Term And Our Financial Performance Could Be Damaged By A Significant Number Of Terminations Or Non-Renewals.

     The standard customer agreement for customers of the Call Center are short-term and can be terminated without cause by either party. We expect that there will be terminations and non-renewals from time to time and that we may not be able to replace all of these clients. Our ability to generate revenues and our financial performance could be damaged by a significant number of terminations or non-renewals of such contracts.

14


Table of Contents

We Could Be Sued For Medical Malpractice

     The information provided by us is intended to be in addition to, and not in substitution for, medical advice from a user’s own physician. However, medical advice may be dispensed both directly by doctors and indirectly through our Healthtrac products. Damage awards in medical malpractice suits can be very high, potentially creating a financial burden that we could not withstand if such a suit were successful and not fully covered by insurance.

Our Common Stock Is Traded On The Over-the-Counter Bulletin Board And As A Result, It May Be More Difficult To Dispose Of Or To Obtain Adequate Quotations As To The Prices Of Our Common Stock.

     Our common stock is quoted on the OTC Bulletin Board and is thinly traded. In the past, our trading price has fluctuated widely, depending on many factors that may have little to do with our operations or business prospectus. In addition, the OTC Bulletin Board is not an exchange and, because trading of the securities on the OTC Bulletin Board is often more sporadic than the trading of securities listed on an exchange of the Nasdaq Stock Market, Inc., you may have difficulty reselling any of the shares you purchase from the selling stockholders.

We May Not Be Able To Obtain The Additional Financing Necessary To Grow Our Business.

     In order to grow our business and finance future acquisitions, we will require additional financing. We currently have a working capital deficiency of $1,618,647. As of February 28, 2003, our accumulated deficit was $119,234,559. Furthermore, we have experienced negative cash flows during each of the last three years of operations. We have historically depended upon capital infusion from the issuance of long term debt and equity securities to provide the cash needed to fund operations. Our ability to continue in business depends upon our continued ability to obtain significant financing from external sources. If additional capital is raised through borrowing or other debt financing, we would incur substantial additional interest expense. Sales of additional equity securities, through a traditional underwritten offering, would dilute, on a pro rata basis, the percentage ownership of all holders of common shares. There can be no assurance that any such financing would be available upon terms and conditions acceptable to us, if at all. The inability to obtain additional financing in a sufficient amount when needed and upon acceptable terms and conditions could have a material adverse effect upon our company and our revenue growth may be adversely affected. If adequate funds are not available on acceptable terms when needed, we may be required to delay, scale-back or eliminate marketing of one or more of our products or development programs or obtain funds through arrangements with collaborative partners or others that may require us to relinquish rights to certain of our technologies, product candidates or potential products that we would not otherwise relinquish. Inadequate funding also could impair our ability to compete in the marketplace and could result in our dissolution.

Our Directors Are Authorized To Issue Preferred Stock Which May Adversely Affect The Voting Power Of Our Shareholders

     We are authorized to issue 150,000,000 each of Class A and Class B preference shares, with such designations, rights and preferences as may be determined from time to time by our board of directors. Accordingly, our board of directors is empowered, without stockholder approval, to issue such preference shares with dividend, liquidation, conversion or other rights which could adversely affect the rights of the our shareholders. The issuance of preference shares could, among other things, adversely affect the voting power of our shareholders and, under certain circumstances, make it more difficult for a third party to gain control of our company, discourage bids for common shares at a premium or otherwise adversely affect the market price for common shares.

We Are Dependent on a Small Number of Customers

     To date, Healthtrac Corporation has derived a significant portion of its revenues from a small number of customers. Many of our customers do not have contracts that extend beyond twelve months. A critical component of the company’s business plan is the acquisition of new customers and the renewal of current contracts. There can be no assurance that we will be successful in developing profitable relationships with new customers or that we will retain existing customers.

Foreign Exchange Rate Risk

     The Company operates internationally and has adopted local currencies as the functional currencies for its foreign subsidiaries because their principal economic activities are most closely tied to the respective local currencies. This exposes the Company to market risk from changes in foreign exchange rates to the extent that transactions are not denominated in the U.S. dollar. In consolidation, the Company converts the accounts of its foreign subsidiaries from the functional currency to the U.S. dollar. As a result, the Company faces the risk that the

15


Table of Contents

foreign currencies will have declined in value as compared to the U.S. dollar, resulting in a foreign currency translation loss.

Item 8. Financial Statements and Supplementary Data

     The Consolidated Financial Statements and Schedule of the Company are listed in Item 15(a) and included herein on pages F-1 through F-23.

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

     The Company has not had any disagreement with its independent auditors on any matter of accounting principles or practices or financial statement disclosure.

PART III

Item 10. Directors and Executive Officers of the Registrant

     Reference is made to the information appearing under the caption “Election of Directors” in the Company’s Proxy Statement to be submitted to the Commission on or before June 28, 2003.

Item 11. Executive Compensation

     Reference is made to the information appearing under the caption “Executive Compensation” in the Company’s Proxy Statement to be submitted to the Commission on or before June 28, 2003.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

     Reference is made to the information appearing under the caption “Security Ownership of Certain Beneficial Owners and Management” in the Company’s Proxy Statement to be submitted to the Commission on or before June 28, 2003.

     Reference is made to the information appearing under the caption “Equity Compensation Plan Information” in the Company’s Proxy Statement to be submitted to the Commission on or before June 28, 2003.

Item 13. Certain Relationships and Related Transactions

     Reference is made to the information appearing under the caption “Certain Relationships and Related Transactions” in the Company’s Proxy Statement to be submitted to the Commission on or before June 28, 2003.

Item 14. Controls and Procedures

     (a)  Evaluation of Disclosure Controls and Procedures

     The Chief Executive Officer and Chief Financial Officer of the Company have concluded, based on their evaluation as of the date within 90 days prior to the date of the filing of this annual report on Form 10-K, the effectiveness of the Company’s disclosure controls and procedures pursuant to Exchange Act Rule 13a-14 and 15d-14. Based on that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were effective in ensuring that all material information required to be filed in this annual report have been made known to them, to allow timely decisions regarding required disclosure.

     (b)  Changes in Internal Controls

     There have been no significant changes in internal controls, or in other factors that could significantly affect internal controls subsequent to the date the Chief Executive Officer and Chief Financial Officer completed their evaluation.

Item 15. Exhibits, Financial Statements, Schedules and Reports on Form 8-K

     (a)  1. Consolidated Financial Statements

     Report of Independent Auditors

     Consolidated Balance Sheets at February 28, 2003 and 2002

16


Table of Contents

     Consolidated Statements of Operations for the years ended February 28, 2003, 2002 and 2001

     Consolidated Statements of Shareholders’ Equity for the years ended February 28, 2003, 2001 and 2000

     Consolidated Statements of Cash Flows for the years ended February 28, 2003, 2002 and 2001

     Notes to Consolidated Financial Statements

     All other schedules are omitted because they are not applicable or the required information is shown in the consolidated financial statements or notes thereto.

     3.     Exhibits

     
Exhibit    
Number   Description

 
99.1   Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 — Edward Sharpless, President, Chief Executive Officer and Tony DiCostunzo, Vice President, Finance & Operations.

     (b)  Reports on Form 8-K

     On November 27, 2002, the Registrant filed a lawsuit in the U.S. District Court for the Northern District of California against Dennis Sinclair (“Sinclair”), Raymond Mol (“Mol”) and Mel Baillie (“Baillie”) (collectively the “Defendants”). The lawsuit is primarily based upon certain sales or acquisitions of the Registrant’s stock engaged in or authorized by the Defendants while they were directors and/or officers of the Registrant in violation of Section 16(b) of the Securities Exchange Act of 1934, 15 U.S.C. ss. 78p(b) (“Section 16”). Section 16 generally restricts certain corporate “insiders” from profiting due to the sale or acquisition of corporate securities within a six month period of the original transaction, by mandating that all such profits shall inure to, and be recoverable by, the issuer of the securities. In the lawsuit, the Registrant seeks the recovery of profits which it believes were received by the Defendants as a result of securities sales or purchases during the approximate period of November, 1999 through November, 2001, pursuant to Section 16 and applicable common law principles governing the conduct of corporate fiduciaries. In addition to the disgorgement of profits, the Registrant also seeks a complete accounting by the Defendants for all transactions which they conducted involving the Registrant’s securities or those of its predecessors while holding corporate office or membership on the Registrant’s Board of Directors.

     Exhibit 99.1 — Certification of Periodic Report, dated December 16, 2002, of the Principal Executive Officer and Principal Financial Officer of the Registrant pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

     On December 12, 2002 one of the Registrant’s directors, Richard Kessler, resigned from the Board of Directors. Mr. Kessler indicated to the Board that he resigned for personal reasons.

     On December 16, 2002, the Principal Executive Officer and Principal Financial Officer of the Registrant provided a written statement on the Registrant’s Quarterly Report on Form 10-Q for the quarter ended August 31, 2002, as amended, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

17


Table of Contents

SIGNATURES

     Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

         
    HEALTHTRAC, INC.
         
    By:   /s/ EDWARD W. SHARPLESS
Edward W. Sharpless

Date: June 13, 2003

     Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

         
Signature   Title   Date

 
 
         
/s/ EDWARD W. SHARPLESS

Edward W. Sharpless
  President, Chief Executive Officer   June 13, 2003
         
/s/ TONY Z. DICOSTANZO

Tony Z. DiCostanzo
  VP, Finance and Operations   June 13, 2003
         
/s/ BOB MOL

Bob Mol
  Director   June 13, 2003
         
/s/ DR. JAMES FRIES

Dr. James Fries
  Director   June 13, 2003
         
/s/ PIERRE PREFONTAINE

Pierre Prefontaine
  Director   June 13, 2003
         
/s/ JUDY HOLLAND

Judy Holland
  Director   June 13, 2003
/s/ DR. ROBERT BAKER

Dr. Robert Baker
  Director   June 13, 2003

18


Table of Contents

CERTIFICATION

I, Edward W. Sharpless, certify that:

  1.   I have reviewed this annual report on Form 10-K of Healthtrac, Inc.;
 
  2.   Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;
 
  3.   Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;
 
  4.   The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

  a)   designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;
 
  b)   evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this annual report (the “Evaluation Date”); and
 
  c)   presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

  5.   The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

  a)   all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and
 
  b)   any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

     6.     The registrant’s other certifying officers and I have indicated in this annual report whether there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

Dated: June 13, 2003

         
    HEALTHTRAC, INC.
         
    By:   /s/ Edward W. Sharpless
President,
Chief Executive Officer

19


Table of Contents

CERTIFICATION

I, Tony Z. DiCostanzo, certify that:

  1.   I have reviewed this annual report on Form 10-K of Healthtrac, Inc.;
 
  2.   Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;
 
  3.   Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;
 
  4.   The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

  a)   designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;
 
  b)   evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this annual report (the “Evaluation Date”); and
 
  c)   presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

  5.   The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

  a)   all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and
 
  b)   any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

     6.     The registrant’s other certifying officers and I have indicated in this annual report whether there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

Dated: June 13, 2003

         
    HEALTHTRAC, INC.
         
    By:   /s/ Tony Z. DiCostanzo
VP, Finance & Operations

20


Table of Contents

HEALTHTRAC, INC.
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
AND FINANCIAL STATEMENT SCHEDULE
For The Year Ended February 28, 2003

         
    Page
   
Report of Independent Auditors
    F-2  
Consolidated Balance Sheets
    F-3  
Consolidated Statements of Operations
    F-4  
Consolidated Statements of Shareholders’ Equity
    F-5  
Consolidated Statements of Cash Flows
    F-6  
Notes to Consolidated Financial Statements
    F-7  

F-1


Table of Contents

REPORT OF INDEPENDENT AUDITORS

To the Board of Directors and Shareholders
Healthtrac, Inc.

     We have audited the accompanying consolidated balance sheets of Healthtrac, Inc. as at February 28, 2003 and 2002 and the related consolidated statements of operations, stockholders’ equity and cash flows for each of the years in the three-year period ended February 28, 2003. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

     We conducted our audits in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

     In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as at February 28, 2003 and 2002 and the results of its operations and its cash flows for each of the years in the three-year period ended February 28, 2003 in accordance with accounting principles generally accepted in the United States of America.

     The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in note 1 to the financial statements, the Company has a working capital deficiency of $1,618,647 as at February 28, 2003 and the Company has suffered recurring losses from operations. These conditions raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Chartered Accountants

Vancouver, Canada
May 16, 2003

F-2


Table of Contents

HEALTHTRAC, INC.
CONSOLIDATED BALANCE SHEETS

(Expressed in United States dollars)

February 28, 2003 and 2002

                     
        2003   2002
       
 
                (Restated - note 2)
ASSETS
               
Current assets:
               
 
Cash and cash equivalents
  $ 186,873     $ 248,391  
 
Accounts receivable, net of allowance of $4,469 (2002 - $235,847)
    407,095       271,302  
 
Employee receivable
          26,417  
 
Inventories
    121,435       48,834  
 
Prepaid expenses and deposits (note 6)
    146,263       256,953  
 
Assets of discontinued operations (note 5)
          98,890  
 
 
   
     
 
 
Total current assets
    860,666       1,111,501  
Equipment (note 7)
    169,994       914,955  
Intellectual property, net of $1,915,459 (2002 - $705,695) accumulated amortization (note 3)
    4,133,359       5,343,123  
 
 
   
     
 
Total assets
  $ 5,164,019     $ 7,208,865  
 
 
   
     
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Current liabilities
               
 
Accounts payable
  $ 1,216,043     $ 1,398,861  
 
Accrued liabilities
    714,974       383,670  
 
Deferred revenue (note 2(g)(iv))
    328,826       456,025  
 
Notes payable (note 8)
          150,000  
 
Current portion of obligations under capital lease (note 9)
    19,470       43,129  
 
Liabilities of discontinued operations (note 5)
    200,000       387,671  
 
 
   
     
 
 
Total current liabilities
    2,479,313       2,819,356  
Obligations under capital lease (note 9)
    9,344       23,176  
Stockholders’ equity:
               
 
Common shares, no par value (note 10):
               
   
Authorized: 300,000,000 (2001 - 300,000,000) common shares
               
   
Issued and outstanding: 223,104,598 (2002 - 199,034,013)
    121,809,921       120,685,444  
 
Shares to be issued
    100,000       754,213  
 
Accumulated deficit
    (119,234,559 )     (117,073,324 )
 
 
   
     
 
 
Total stockholders’ equity
    2,675,362       4,366,333  
 
 
   
     
 
Total liabilities and stockholders’ equity
  $ 5,164,019     $ 7,208,865  
 
 
   
     
 
Future operations (note 1)
               
Commitment and contingencies (notes 10(b) and 16)
               

See accompany notes

F-3


Table of Contents

HEALTHTRAC, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS

(Expressed in United States dollars)

                             
        Year ended   Year ended   Year ended
        February 28,   February 28,   February 28,
        2003   2002   2001
       
 
 
                (Restated – note 5)   (Restated – note 5)
Revenue (notes 12 and 13)
  $ 3,604,433     $ 2,780,472     $ 770,153  
Costs and expenses:
                       
   
Direct costs
    663,894       534,753        
   
Selling, general and administrative expenses (schedule)
    3,580,063       5,146,813       3,569,661  
   
Amortization
    1,393,988       843,856       36,941  
   
Foreign exchange losses
    2,441       82,647       38,692  
   
Loss on sale of equipment
          5,843        
   
Loss on deposit to acquire assets
                60,000  
   
Write-down of equipment and other assets
    435,503              
   
Write-down of other assets
    29,669              
   
Lawsuit settlements (note 16(c))
          (184,980 )      
 
   
     
     
 
 
    6,105,558       6,428,932       3,705,294  
 
   
     
     
 
Loss before undernoted
    (2,501,125 )     (3,648,460 )     (2,935,141 )
Other income (expense):
                       
   
Interest income and miscellaneous
    (2,066 )     6,284       93,238  
   
Gain on forgiveness of debt
    338,204              
 
   
     
     
 
 
    336,138       6,284       93,238  
 
   
     
     
 
Loss from continuing operations
    (2,164,987 )     (3,642,176 )     (2,841,903 )
Income (loss) from discontinued operations (note 5)
    3,752       (6,274,633 )     (3,869,214 )
 
   
     
     
 
Loss for the year
  $ (2,161,235 )   $ (9,916,809 )   $ (6,711,117 )
 
   
     
     
 
Loss per common share (note 2(i)) — basic and diluted:
                       
 
Continuing operations
  $ (0.01 )   $ (0.02 )   $ (0.02 )
 
Discontinued operations
          (0.04 )     0.03 )
 
   
     
     
 
Loss for the year
  $ (0.01 )   $ (0.06 )   $ (0.05 )
 
   
     
     
 
Weighted average number of shares outstanding -basic and diluted
    214,797,250       154,543,871       126,934,127  
 
   
     
     
 

See accompanying notes

F-4


Table of Contents

HEALTHTRAC, INC.
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(Expressed in United States dollars)

                                           
      Common Shares                        
     
                       
              Assigned   Shares to   Accumulated        
      Number   Value   be issued   deficit   Total
     
 
 
 
 
Balance, February 29, 2000
    123,001,504       102,492,038             (100,445,398 )     2,046,640  
Shares issued during the year:
                                       
 
Exercise of CCAA warrants (note 10(b))
    1,170,060                          
 
For cash pursuant to private placements
    1,730,375       4,310,800                   4,310,800  
 
For employees’ and directors’ compensation
    1,295,000       754,950                   754,950  
 
For settlement of debt
    49,629       19,344                   19,344  
 
For consulting services
    88,181       6,000                   45,000  
 
Issue on acquisition of TAME
    300,000       39,000                          
 
Issued on acquisition of Sullivan Park
    200,000       375,000                   375,000  
 
Shares to be issued on acquisition of Sullivan Park
                2,700,000             2,700,000  
 
Shares to be issued for cash received pursuant to private placements
                2,005,000             2,005,000  
 
Share issue costs
          (475,650 )                 (475,650 )
 
Loss for the year
                      (6,711,117 )     (6,711,117 )
 
   
     
     
     
     
 
Balance, February 28, 2001
    127,834,749       107,521,482       4,705,000       (107,156,515 )     5,069,967  
Shares issued during the year:
                                       
 
Exercise of CCAA warrants (note 10(b))
    732,433                          
 
Issued for acquisition of Sullivan Park
    6,500,000       2,210,000       (2,700,000 )           (490,000 )
 
Shares issued and to be issued for acquisition of Healthtrac (note 4)
    13,212,976       4,492,412       107,588             4,600,000  
 
Issued on acquisition of Med Wire assets (note 5)
    241,935       150,000                   150,000  
 
Issued on acquisition of specific assets of Healthscape (note 5)
    631,579       240,000                   240,000  
 
Shares issued for cash received pursuant to private placements
    42,985,717       4,744,125       (2,005,000 )           2,739,125  
 
Shares to be issued for settlement of debt
                6,000             6,000  
 
Shares issued for settlement of debt (note 4)
    3,716,090       971,767                   971,767  
 
Shares issued for services
    1,425,777       123,658                   123,658  
 
Shares issued for employees’ and directors’ compensation
    1,018,181       566,000                   566,000  
 
Shares issued for severance pay
    1,000,000       100,000                   100,000  
 
Shares returned to treasury and cancelled
    (265,424 )                        
 
Shares to be issued for cash received pursuant to private placements
                640,625             640,625  
 
Share issue costs
          (24,000 )                 (24,000 )
 
Subscription receivable
          (410,000 )                 (410,000 )
 
Loss for the year
                      (9,916,809 )     (9,916,809 )
 
   
     
     
     
     
 
Balance, February 28, 2002, brought forward
    199,034,013       120,685,444       754,213       (117,073,324 )     4,366,333  
Shares issued during the year:
                                       
 
For cash pursuant to private placements
    20,040,238       859,124       (561,625 )           297,499  
 
Shares to be issued for cash received pursuant to private placements
                15,000             15,000  
 
Shares issued for employee compensation ($50,000 cash received from private placement)
    1,000,000       130,000                   130,000  
 
Subscription receivable
          (77,500 )                 (77,500 )
 
Shares issued for services
    1,450,000       45,500                   45,500  
 
Shares issued and to be issued for acquisition of Healthtrac (note 3)
    431,293       107,588       (107,588 )            
 
Shares to be issued for settlement of debt
    1,149,054       59,765                   59,765  
 
Loss for the year
                            (2,161,235 )     (2,161,235 )
 
   
     
     
     
     
 
Balance, February 28, 2003
    223,104,598       121,809,921       100,000       (119,234,559 )     2,675,362  
 
   
     
     
     
     
 

See accompanying notes

F-5


Table of Contents

HEALTHTRAC, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS

(Expressed in United States dollars)

                             
        Year ended   Year ended   Year ended
        February 28,   February 28,   February 28,
        2003   2002   2001
       
 
 
                (Restated - note 5)   (Restated - note 5)
Cash flows from operating activities:
                       
 
Loss for the year
  $ (2,161,235 )   $ (9,916,809 )   $ (6,711,117 )
 
Adjustments for:
                       
   
Loss from discontinued operations
    (3,752 )     6,274,633       3,869,214  
   
Non-cash compensation
    80,000       566,000       754,950  
   
Non-cash severance payment
          100,000        
   
Non-cash services and purchases
    45,500       129,658       64,344  
   
Amortization
    1,393,988       843,856       36,941  
   
Write-down of equipment
    435,503              
   
Write-down of other assets
    29,669              
   
Loss on sale of equipment
          5,843        
   
Gain on forgiveness of debt
    (338,204 )            
 
Changes in non-cash operating working capital:
                       
   
Accounts receivable
    (134,793 )     106,816       (57,353 )
   
Employee receivable
    (3,252 )     7,192       (33,609 )
   
Loan receivable
          75,000       (75,000 )
   
Prepaid expenses and advances
    110,689       (9,533 )     28,108  
   
Inventories
    (72,601 )     50,656       (270 )
   
Deferred revenue
    (127,199 )     45,787        
   
Accounts payable
    101,853       179,284       277,374  
   
Accrued liabilities
    331,304       320,605       20,523  
 
 
   
     
     
 
 
Cash flow used in continuing operations
    (312,530 )     (1,221,012 )     (1,825,895 )
 
Cash used in discontinued operations
    40,997       (1,838,270 )     (2,803,701 )
 
 
   
     
     
 
 
Cash flow used in operations
    (271,533 )     (3,059,284 )     (4,629,596 )
Investments:
                       
 
Acquisition of equipment
    (36,060 )     (122,709 )     (1,061,615 )
 
Acquisition costs (note 3)
          (136,585 )      
 
Cash acquired on acquisition
          57,091       3,248  
 
 
   
     
     
 
 
Cash flow used in investments
    (36,060 )     (202,203 )     (1,058,367 )
Financing:
                       
 
Note payable
    (36,702 )     100,000        
 
Repayment of capital lease obligation
    (37,491 )     (69,757 )     (30,878 )
 
Issuance of common shares for cash
    270,000       2,329,125       4,310,800  
 
Shares to be issued
    15,000       640,625       2,005,000  
 
Share issue costs
          (24,000 )     (475,650 )
 
 
   
     
     
 
 
Cash flow provided by financing
    210,807       2,975,993       5,809,272  
 
 
   
     
     
 
Increase (decrease) in cash and cash equivalents
    (96,786 )     (285,495 )     121,309  
Increase (decrease) in cash of discontinued operations
    41,104       39,476       (74,743 )
Cash and cash equivalents, beginning of year
    248,391       494,410       447,844  
 
 
   
     
     
 
Cash and cash equivalents, end of year from
                   
continuing operations
  $ 186,873     $ 248,391     $ 494,410  
 
 
   
     
     
 

Non-cash transactions and supplemental disclosures (note 15).
See accompanying notes

F-6


Table of Contents

HEALTHTRAC, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
February 28, 2003

1.   Future operations:
 
    These financial statements have been prepared on the going concern basis, which assumes the realization of assets and the settlement of liabilities in the normal course of business. The application of the going concern concept is dependent on the Company’s ability to generate future profitable operations and receive continued financial support from its shareholders and from external financing. The Company incurred a loss from operations of $2,161,235 for the year ended February 28, 2003 (2002 — $9,916,809) and has an accumulated deficit of $119,234,559 at February 28, 2003 (2002 — $117,073,324). For the year ended February 28, 2003, the Company used $312,530 in cash to fund continuing operations, provided $40,997 in cash from discontinued operations, used $36,050 in cash to fund investing activities and generated $210,807 in cash from financial activities for a net cash outflow of $96,786. As at February 28, 2003, the Company has a working capital deficiency of $1,618,647.
 
    Management projects that the Company will require additional cash and working capital to fund planned operations and capital asset additions for fiscal 2004 which management estimates will total approximately $500,000. Although management is of the opinion that sufficient cash will be obtained from operations and external financing to meet the Company’s liabilities and commitments as they become due in fiscal 2004, if external financings become required, there can be no assurance that funds will be available when required on an economic basis to the Company. The ability of the Company to continue as a going concern and realize the carrying value of its assets is dependent on the Company’s ability to increase its revenues by increasing its customer base and reducing its operating costs so that the Company achieves profitable operations.
 
    These financial statements do not reflect any adjustments that would be necessary should the Company be unable to continue as a going concern and therefore be required to realize its assets and discharge its liabilities in other than the normal course of operations.
 
    May 16, 2003, subsequent to February 28, 2003 the Company has raised nil in external financing through the issuance of private placements. If the Company is unable to obtain sufficient funds for operations, it will be required to reduce operations or liquidate assets.
 
2.   Significant accounting policies:

  (a)   Basis of presentation:
 
      These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. Except as disclosed in note 17, these principles do not differ materially from measurement accounting principles generally accepted in Canada.

F-7


Table of Contents

2.   Significant accounting policies (continued):

  (a)   Basis of presentation (continued):
 
      These consolidated financial statements include the accounts of the Company and its subsidiaries, all of which are wholly owned. All subsidiaries were acquired from unrelated parties and have been accounted for using the purchase method. Their results of operations have been included from the respective effective dates of acquisition. All significant intercompany balances and transactions have been eliminated.

     
Canadian subsidiaries   United States subsidiaries

 
Canadian-American Communications Inc.   Northnet Telecommunications Inc.
Canadian Northstar Transmission Systems Ltd.   eCommerce Solutions inc.
Preferred Telemangement Inc. (“PTI)   Sullivan Park, Inc. (“Sullivan Park”)
Cam-Net Cellular Inc.   Healthtrac Corporation

  (b)   Cash and cash equivalents:
 
      Cash and cash equivalents includes overnight repurchase agreements and certificates of deposit having a term to maturity of three months or less when acquired. For presentation purposes, the Company considers all highly liquid debt instruments with original terms to maturity of three months or less when acquired to be cash equivalents.
 
  (c)   Inventories:
 
      Inventories consist of various publications and written materials for the Healthcare segment. Inventories are stated at the lower of average cost and net realizable value.
 
  (d)   Equipment:
 
      Equipment is recorded at cost. Amortization is recorded using the straight-line method over the following estimated useful lives:

         
Asset   Term

 
Office equipment
  5 - 7 years
Computer hardware
  3 - 5 years
Computer software
  3 - 5 years

      Leasehold improvements are depreciated on a straight-line basis over the shorter of the lease term or their estimated useful lives.

F-8


Table of Contents

2.   Significant accounting policies (continued):

  (e)   Intellectual property:
 
      Intellectual property representing the algorithms and data used in the health questionnaires as being amortized on a straight-line basis over five years.
 
  (f)   Impairment of long-lived assets and long-lived assets to be disposed of:
 
      The Company accounts for long-lived assets, which includes equipment, intellectual property and goodwill, in accordance with the provisions of SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets”. This Statement requires that long-lived assets and certain identifiable intangibles and goodwill related to such assets, be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.
 
      During 2002, the Company reviewed the carrying value of goodwill acquired on acquisition of Sullivan Park. The review was initiated as a result of the settlement of the Sullivan Park lawsuit and the subsequent shut down of those operations. As a result of the shut down, the Company determined that the estimated discounted cash flows were nil and the goodwill was written off completely. The impairment charge is included in discontinued operations (note 5).
 
  (g)   Revenue recognition:

  (i)   Call Center division:
 
      The Call Center provides transaction processing, centralized billing, customer and technical support, order entry, order fulfillment, bill collection, help desk services and dispatch functions. Revenue is recognized based on monthly per customer transactions for standard services in accordance with contractual arrangements.
 
  (ii)   E’Commerce division (included in discontinued operations):
 
      Commissions earned from the sale of third party products ordered from the Company’s internet site, whereby the Company does not take title to the products in advance of sale, are recognized, on a net basis when the product has been delivered, the fee is fixed and determinable and collection is probable.
 
      Revenues earned from the sale of products ordered from the Company’s internet site, whereby the Company takes title to the product in advance of sale and stocks the product in inventories, are recognized when the product has been delivered, the fee is fixed and determinable and collection is probable.

F-9


Table of Contents

2.   Significant accounting policies (continued):

  (g)   Revenue recognition (continued):

  (ii)   E’Commerce division (continued):
 
      Revenues from consulting services related to website design and development projects are recognized upon completion of those projects. Revenues from website hosting services are recognized monthly as billed.
 
      The division’s sale arrangements do not include post sales customer support, discounts, warranties or other ongoing arrangements.
 
  (iii)   Call Direct Catalogue division (included in discontinued operations):
 
      The Catalogue division acquires products from suppliers for resale, advertises the products in its catalogues and sells the product based on telephone orders. Revenue is earned when product is delivered to the customer and collection is probable.
 
  (iv)   Healthcare division:
 
      Service fees for the evaluation of health assessment questionnaires and the development and monitoring of health education plans are initially deferred and recognized as services are provided and the revenues earned.
 
      Sales of publications and written materials are recognized upon shipment, at which time title is transferred to the customer.
 
      Royalty revenue from licensing of the Company’s software is recognized in accordance with the provisions of SOP 97-2 “Software Revenue Recognition”, as amended. Royalty revenue is recognized upon the completion and assessment of questionnaires returned to the licensee.

  (h)   Income taxes:
 
      Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. When the realization of deferred tax assets is not considered to be more likely than not, a valuation allowance is provided.

F-10


Table of Contents

2.   Significant accounting policies (continued):

  (i)   Loss per share:
 
      Loss per share has been calculated using the weighted average number of shares outstanding during the year.
 
      Diluted loss per share for the year is the same as basic loss per share due to the loss for all periods presented. The following securities could potentially dilute basic EPS in the future but were not included in the computation of diluted EPS because to do so would have been anti-dilutive for the periods presented:

                         
    2003   2002   2001
   
 
 
Warrants
    6,135,000       6,135,000        
Options (note 10(e))
    260,000       6,776,000       6,952,500  

  (j)   Foreign exchange:
 
      The functional currency of all of the Company’s operations is the United States dollar except for its Canadian subsidiaries for which it is the Canadian dollar. Subsidiary amounts originally measured in other than the Company’s functional currency, are translated to the functional currency by using the current rate method under which assets and liabilities are translated at the exchange rate at the balance sheet date and revenues, expenses, gains and losses are translated at the exchange rate at the dates on which those transactions occurred except that weighted average exchange rate is used to translate normal recurring transactions. Translation adjustments are reported and accumulated in a separate component of equity, if material. No translation adjustments have been incurred for the years presented.
 
      Balance sheet items denominated in other than the functional currency are translated into the functional currency dollars at exchange rates prevailing at the balance sheet date for monetary items and at exchange rates in effect at the transaction date for non-monetary items. Statement of operations items are translated at actual or average rates prevailing during the year. Gains and losses on translation of balance sheet items are included in operations as incurred.
 
  (k)   Use of estimates:
 
      Management of the Company has made a number of estimates and assumptions relating to the reporting of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in preparing these financial statements in conformity with accounting principles generally accepted in the United States. Actual results could differ from those estimates. In these consolidated financial statements, significant areas requiring the use of management estimates relate to the determination of collectibility of accounts receivable, the recoverability of equipment and intellectual property and rates for depreciation and amortization.

F-11


Table of Contents

2.   Significant accounting policies (continued):

  (l)   Financial instruments:
 
      The fair values of cash and cash equivalents, amounts receivable, accounts payable, accrued liabilities and obligations under capital lease approximate their carrying values due to the short-term to maturity of these items.
 
      The Company’s credit risk is limited to the amounts disclosed on the balance sheet. The Company has significant concentrations of credit risk as certain customers or classes of customers aggregate greater than 10% of the Company’s outstanding accounts receivable (note 13).
 
      The Company operates in Canada and the United States which gives rise to a risk that its earnings and cash flows may be negatively impacted by fluctuations in interest and foreign exchange rates. The Company has not entered into derivative or other financial instruments to hedge these risks.
 
  (m)   Stock-based compensation plans:
 
      The Company applies the intrinsic value-based method of accounting prescribed by Accounting Principles Board (“APB”) Opinion No. 25, “Accounting for Stock Issued to Employees”, and related interpretations to account for its employee stock options plans. Under this method, compensation expense is recorded on the measurement date, which is generally the date of grant, only if the current market price of the underlying stock exceeds the exercise price. SFAS No. 123, “Accounting for Stock-Based Compensation”, established accounting and disclosure requirements using a fair value-based method of accounting for stock-based employee compensation plans. As allowed by SFAS No. 123, the Company has elected to continue to apply the intrinsic value-based method of accounting described above, and has adopted the disclosure requirements of SFAS No. 123 for employee stock option grants. Option grants to non-employees will be recognized at their fair value as the services are provided and the options earned.
 
      The Company accounts for stock-based compensation associated with the repricing of employee stock options in accordance with the provisions of FASB Interpretation No. 44, “Accounting for Certain Transactions involving Stock Compensation” (“FIN 44”). For accounting purposes, the repricing of existing stock options requires variable accounting for the new options granted from the date of modification. Variable accounting requires that the intrinsic value, being the excess of the current market price at the end of each reporting period in excess of the exercise price of the repriced options, be expensed as non-cash stock-based compensation expense, until such time as the repriced options are exercised, expire or are otherwise forfeited. Any increase in the intrinsic value of the repriced options will decrease reported earnings, and any subsequent decreases in value will increase reported earnings.

F-12


Table of Contents

2.   Significant accounting policies (continued):

  (m)   Stock-based compensation plans (continued):
 
      The closing price of the Company’s common stock on February 28, 2003 was $0.03 per share and therefore the Company recognized employee non-cash compensation expense charges of nil for the year ended February 28, 2003 related to repriced stock options. There is a potential for such a variable non-cash charges in each reporting period until all of the Company’s repriced stock options are exercised, forfeited or expire.
 
      Had the Company determined compensation cost based on the fair value at the grant date for its stock options under SFAS No. 123, the Company’s net loss would have been increased to the pro forma amounts indicated below:

                         
    2003   2002   2001
   
 
 
Compensation expense
  $ 197,000     $ 746,000     $ 8,629,883  
Pro forma loss
    2,358,235       10,662,809       15,341,000  
Pro forma loss per share
  $ 0.01     $ 0.07     $ 0.12  

      The weighted average fair value of employee options granted during the year was $0.10 (2002 — $0.28; 2001 — $1.25) estimated using the Black-Scholes option-pricing model with the following weighted average assumptions:

                         
    2003   2002   2001
   
 
 
Risk free interest rate
    4.50 %     4.75 %     5.00 %
Annual dividends
                 
Expected lives
    50 %     50 %     50 %
Volatility
    150 %     121 %     131 %

  (n)   Recently adopted accounting standards:
 
      During 2002, the Financial Accounting Standards Board has issued the following new pronouncements that impacted the Company:

    In August 2001, the Financial Accounting Standards Board (“FASB”) issued FAS No. 143, “Accounting or Asset Retirement Obligations” (“SFAS No. 143”), which requires entities to record the fair value of a liability for an asset or an asset retirement obligation in the period in which it is incurred and a corresponding increase in the carrying amount of the related long-lived asset. SFAS No. 143 was effective for the Company’s current fiscal year.

F-13


Table of Contents

2.   Significant accounting policies (continued):

  (n)   Recently adopted accounting standards (continued):

    In July 2002, FASB released SFAS No. 146, “Accounting for costs associated with Exit or Disposal Activities”, (“SFAS No. 146”), which addresses the financing accounting and reporting for costs associated with exit or disposal activities. SFAS No. 146 relates to the recognition of a liability for a cost associated with an exit or disposal activity and requires that a liability be recognized for these costs only when the liability is incurred., that is, when it meets the definition of a liability under FASB’ conceptual framework. SFAS No. 146 also established fair value as the objective for initial measurement of liabilities related to exit or disposal activities. As a result, SPAS 146 significantly reduces an entity’s ability to recognize a liability for future expenses related to restructuring. SFAS 146 was effective for exit and disposal activities initiated after December 31, 2002.
 
    In December 2002, FASB released SFAS No. 148, “Accounting for Stock-based Compensation - -Transition and Disclosure”. This statement amends FASB Statement No. 123. “Accounting for Stock-based Compensation”, to provide alternative methods of transition for a voluntary change to the fair value base method of accounting for stock-based compensation. In addition, this Statement amends the disclosure requirements of Statement 123 to require prominent disclosures in both annual and interim financial statements about the method of accounting for stock-based compensation and the effect of the method used on reported results.

      The adoption of SFAS No. 143 or SFAS No. 146 on January 1, 2003 did not have a material impact on the Company’s reported financial results. The disclosure requirements in SFAS No. 148 have been adopted in these consolidated financial statements.

3.   Acquisition of the business of Healthtrac, Inc.:
 
    On August 3, 2001, the Company acquired all of the shares of Healthtrac, Inc. (“Healthtrac”) which operated an analytical health assessment program. The Company issued 13,212,976 common shares on closing and issued 431,293 common shares subsequently for a total fair value of $4,600,000 in share consideration. This acquisition has been accounted for as a purchase of the business of Healthtrac under the purchase method with effect from August 3, 2001. As part of the acquisition, the Company issued 3,716,090 common shares with a fair value of $971,767 to creditors of the acquired company to settle debt obligations.

F-14


Table of Contents

3.   Acquisition of the business of Healthtrac, Inc. (continued):
 
    Details of the fair value assigned to the assets acquired and liabilities assumed in the acquisition are as follows:

           
Assets acquired:
       
 
Current assets
  $ 520,962  
 
Equipment
    83,387  
 
Intellectual property
    6,048,818  
 
 
   
 
 
    6,653,167  
Liabilities assumed:
       
 
Current liabilities
    1,866,582  
 
Long-term debt
    50,000  
 
 
   
 
 
    1,916,582  
 
 
   
 
Net assets acquired
  $ 4,736,585  
 
 
   
 
Consideration paid:
       
 
Shares
  $ 4,600,000  
 
Acquisition costs
    136,585  
 
 
   
 
 
  $ 4,736,585  
 
 
   
 

4.   Other acquisitions:

  (a)   Medwired Corporation:
 
      On April 20, 2001, the Company closed its acquisition of proprietary web portal development and content management software from Medwired Corporation for $50,000 in cash and 241,935 common shares of the Company with a fair value of $150,000. The total proceeds were allocated to equipment. In fiscal 2003, management made a decision to abandon the business and wrote-down the equipment to nil.
 
  (b)   Healthscape, Inc.:
 
      Pursuant to an agreement dated May 30, 2001, the Company acquired proprietary software from Healthscape, Inc. on June 26, 2001 for $5,000 in cash and 631,579 common shares of the Company with a fair value of $240,000. The total proceeds were allocated to equipment. In fiscal 2003, management made a decision to abandon the business and wrote-down the equipment to nil.

5.   Discontinued operations:
 
    On February 28, 2002, the Company closed its catalogue sales division. During the third quarter of fiscal 2003, the Company discontinued its e-commerce segment which had been substantially curtailed in fiscal 2002. As a result, the catalogue and e-commerce divisions represent discontinued operations to the Company. In accordance with generally accepted accounting principles in the United States, prior year and current year figures have been reclassified in the consolidated financial statements to separately reflect the assets, liabilities, revenues and expenses under discontinued operations accounting.

F-15


Table of Contents

5.      Discontinued operations (continued):

    Summarized financial information for the discontinued operations is as follows:

                     
        2003   2002
       
 
Assets
               
Cash
  $     $ 35,267  
Accounts and employee receivables
          34,557  
Inventory
          544  
Prepaid expenses
          28,522  
Equipment, net of accumulated amortization
          160,714  
 
   
     
 
Assets of discontinued operations
  $     $ 259,604  
 
   
     
 
Liabilities
               
Accounts payable
  $     $ 287,604  
Accrued liabilities
    200,000       100,067  
 
   
     
 
Liabilities of discontinued operations
  $ 200,000     $ 387,671  
 
   
     
 

    The Company expects to settle the remaining liabilities from discontinued operations in 2004. The Company is negotiating the settlements with the intention of settling at less than the recorded amount of $200,000. However, there can be no certainty that this will be achieved.

                           
      2003   2002   2001
     
 
 
Revenue
  $ 50,304     $ 930,360     $ 1,810,299  
Expenses:
                       
 
Direct costs
    21,540       437,939       478,497  
 
Selling and administrative costs
    54,624       2,891,272       3,873,534  
 
Amortization
    26,780       890,846       1,361,206  
 
Write-down of equipment
    134,513       1,379,883        
 
Write-down of other assets
    52,427              
 
Impairment of goodwill
          1,522,758        
 
Other
          82,295       (33,724 )
Gain on forgiveness of debt
    (243,332 )            
 
   
     
     
 
Net income (loss) from discontinued operations
  $ 3,752     $ (6,774,633 )   $ (3,869,214 )
 
   
     
     
 

6.     Prepaid expenses and deposits:

                 
    2002   2001
   
 
Prepaid expenses
  $ 5,144     $ 104,584  
Deposits
    141,119       152,369  
 
   
     
 
 
  $ 146,263     $ 256,953  
 
   
     
 

F-16


Table of Contents

7.      Equipment:

                         
            Accumulated        
            amortization   Net book
2003   Cost   and write-down   value

 
 
 
Office equipment
  $ 274,104     $ 135,912     $ 138,192  
Computer hardware
    87,590       74,227       13,363  
Leasehold improvements
    24,980       6,541       18,439  
 
   
     
     
 
 
  $ 386,674     $ 216,680     $ 169,994  
 
   
     
     
 
                           
              Accumulated   Net book
2002   Cost   amortization   value

 
 
 
Continuing operations:
                       
 
Office equipment
  $ 293,629     $ 83,246     $ 210,383  
 
Computer hardware
    164,867       104,423       60,444  
 
Computer software
    543,247       84,272       458,975  
 
Leasehold improvements
    329,301       304,862       24,439  
 
 
   
     
     
 
 
  $ 1,331,044     $ 576,803     $ 754,241  
 
 
   
     
     
 
Discontinued operations:
                       
 
Office equipment
  $ 770,104     $ 677,589     $ 92,515  
 
Computer hardware
    1,504,770       1,468,975       35,795  
 
Computer software
    102,344       69,940       32,404  
 
 
   
     
     
 
 
  $ 2,377,218     $ 2,216,504     $ 160,714  
 
 
   
     
     
 

8.      Notes payable:

                 
    2003   2002
   
 
Note payable to a shareholder with interest at 1% over Bank of America’s prime rate due on February 3, 2003 (note 14)
  $     $ 50,000  
Note payable with interest at 8% due January 31, 2002. The note is secured by a pledge of an aggregate of 300,000 common shares held by a director
          100,000  
 
   
     
 
 
  $     $ 150,000  
 
   
     
 

    The $100,000 note payable was not paid on January 31, 2002 and the lender exercised their right under the default provision to receive the 300,000 common shares of the director on March 5, 2002. The creditor sold the shares for $34,360 of cash. The remaining payments have been reclassified to accounts payable.

F-17


Table of Contents

9.      Obligations under capital lease:

                 
    2003   2002
   
 
Year ending February 28 (2004 - 29):
               
2003
  $     $ 47,961  
2004
    19,470       14,060  
2005
    11,040       10,224  
2006
    920       1,704  
 
   
     
 
Total minimum lease payments
    31,430       73,949  
Amount representing interest from 10% to 13%
    2,616       7,644  
 
   
     
 
Present value of net minimum capital lease payments
    28,814       66,305  
Current portion of obligation under capital lease
    19,470       43,129  
 
   
     
 
 
  $ 9,344     $ 23,176  
 
   
     
 

    Interest of $4,695 (2002 — $8,550) relating to capital lease obligations has been included in interest expense.

10.     Share capital:

(a)   Authorized:

      300,000,000 common stock without par value
150,000,000 class A preference stock without par value
150,000,000 class B preference stock without par value

(b)   Commitments to issue common shares:
 
    During fiscal 1998, the Company committed to issue 13,000,000 shares to former creditors under a reorganization plan. As at February 28, 2003, 10,581,455 (2002 — 10,581,455; 2001 — 9,849,022) shares have been issued to creditors leaving an outstanding commitment to issue 2,418,545 (2002 — 2,418,545; 2001 - 3,150,978) shares.
 
(c)   Reduction of common share stated capital:
 
    On August 22, 1996, the shareholders of the Company passed a special resolution to reduce the stated capital of the Company’s common shares by $86,729,000 (CDN $117,535,000). For accounting purposes, the recorded amounts for common shares and deficit have not been adjusted.
 
(d)   Warrants:
 
    On June 4, 2001, the Company issued 65,000 share purchase warrants which expire June 4, 2004. Each warrant entitles the holder to purchase one common share for $0.56. As at February 28, 2003, 65,000 of these warrants were unexercised.
 
    On July 16, 2001, the Company issued 20,000 share purchase warrants which expire July 16, 2003. Each warrant entitles the holder to purchase one common share for $0.40. As at February 28, 2003, 20,000 of these warrants were unexercised.

F-18


Table of Contents

10.     Share capital (continued):

(d)   Warrants (continued):
 
    On August 3, 2001, the Company issued 50,000 share purchase warrants to a former employee in place of 45,000 options previously granted to that employee. The warrants expire on August 3, 2003. Each warrant entitles the holder to purchase one common share for $0.24. As at February 28, 2003, 50,000 of these warrants were unexercised.
 
    On January 2, 2002, the Company issued 6,000,000 share purchase warrants to the former President as part of his severance package. The warrants expire on January 2, 2007. Each warrant entitles the holder to purchase one common share for $0.10, the market price of the Company’s common shares at the time of the issuance of the share purchase warrants. As at February 28, 2003, 6,000,000 of these warrants were unexercised. The Company has cancelled these share purchase warrants.
 
(e)   Stock options:
 
    The Company has a stock option plan, which allows the Company, at the discretion of the Board of Directors, to issue options to employees, directors and consultants to purchase common shares of the Company. Stock purchase options are granted having exercise prices based on the market price at the date of grant. The stock options expire at various dates ranging from July 28, 2010 to November 5, 2011. The stock options vest in accordance with each individual stock option agreement.
 
    The following summarizes changes in stock options for the last three reporting years:

                                                 
    2003   2002   2001
   
 
 
            Weighted           Weighted           Weighted
            average           average           average
            exercise           exercise           exercise
    Shares   price   Shares   price   Shares   price
   
 
 
 
 
 
Outstanding, beginning of year, as previously reported
    6,776,000     $ 0.14       6,952,500     $ 0.56       100,000     $ 1.28  
Outstanding, beginning of year, as repriced
                6,952,500       0.15              
Granted
    6,000,000       0.10       2,696,000       0.13       6,952,500       0.56  
Forfeited
    (12,516,000 )     (0.12 )     (2,872,500 )     0.48       (100,000 )     1.28  
 
   
     
     
     
     
     
 
Outstanding, end of year
    260,000     $ 0.15       6,776,000     $ 0.14       6,952,500     $ 0.56  
 
   
     
     
     
     
     
 

F-19


Table of Contents

10.    Share capital (continued):

(e)   Stock options (continued): The Company has the following stock purchase options outstanding and vested at February 28, 2003:

                         
    Number   Price   Expiry
   
 
 
Employees
    60,000     $ 0.15     July 28, 2010
Director
    200,000       0.15     November 5, 2011
 
   
     
     
 
Total
    260,000     $ 0.15          
 
   
     
     
 

    On June 10, 2002, the President and Chief Executive Officer resigned from the Company and consequently, forfeited 3,000,000 unvested options at $0.10.
 
    During the year, the expiry date was extended for 350,000 options held by former employees. No additional compensation was required to be recognized as a result of this modification.
 
    On April 1, 2002, 2,000,000 stock options were granted to a consultant of the Company which vest in accordance with certain performance criteria and expired on April 1, 2003. No compensation was required to be recorded to February 28, 2003, for this award.
 
    The Company cancelled a majority of the outstanding options in the fourth quarter as the option holders no longer were employed by the Company or no longer directors or consultants of the Company.
 
(f)   Issuance of shares for non-monetary consideration:
 
    Shares issued for employee and director compensation, to third parties for services rendered, for settlement of debt and for the acquisition of assets or businesses are recorded based upon the market trading value of the shares at the date of the related agreements to issue the shares.

F-20


Table of Contents

11.    Income taxes:

    Loss before income taxes consists of the following:

                         
    2003   2002   2001
   
 
 
Canada
  $ (1,362,650 )   $ (2,954,858 )   $ (2,943,317 )
United States
    (798,585 )     (6,961,951 )     (3,767,800 )
 
   
     
     
 
 
  $ (2,161,235 )   $ (9,916,809 )   $ (6,711,117 )
 
   
     
     
 

    Income tax recovery attributable to loss from operations differs from the amounts computed by applying the combined federal and provincial income tax rate of approximately 39.6% (2002 — 44.6%) to loss before taxes as a result of the following:

                         
    2003   2002   2001
   
 
 
At statutory rates
  $ (856,000 )   $ (4,422,897 )   $ (2,653,000 )
U.S. tax rate difference
    6,000       300,000        
Losses and other temporary differences not recognized
    800,000       4,072,897       2,348,000  
Non-deductible items and other
    50,000       50,000       305,000  
 
   
     
     
 
 
  $     $     $  
 
   
     
     
 

    The tax effects of temporary differences that give rise to significant portions of the future tax assets and liabilities are as follows:

                     
        2003   2002
       
 
Deferred tax assets:
               
 
Canada:
               
   
Net operating losses carry forward
  $ 5,585,000     $ 7,758,282  
   
Other
           
   
 
   
     
 
 
    5,585,000       7,758,282  
 
United States
               
   
Net operating losses carry forward
    4,747,000       4,437,095  
   
 
   
     
 
 
    10,332,000       12,195,377  
Valuation allowance
    (10,332,000 )     (12,195,377 )
   
 
   
     
 
Net deferred tax assets
  $     $  
   
 
   
     
 

    The Company had losses carried forward for Canadian income tax purposes of $4,528,732 expire unused during the year.

F-21


Table of Contents

11.     Income taxes (continued):

    As at February 28, 2002, the Company has accumulated losses for tax purposes of approximately $28,091,534 which may be carried forward to reduce taxable income in future years. These losses may be claimed no later than:

                 
    Canada   United States
   
 
2004
  $ 1,734,000     $  
2005
    2,350,000        
2006
    3,075,000        
2007
           
2008
    2,803,000        
2009
    2,905,000        
2010
    1,237,000        
2020
          1,460,000  
2021
          3,014,000  
2022
          6,962,000  
2023
          799,000  
 
   
     
 
 
  $ 14,104,000     $ 12,235,000  
 
   
     
 

12.    Segmented information:

    During the years presented, the Company had four operating segments – a healthcare division, a call center division, a catalogue division and an e’commerce division. The health division, call center and e’commerce segments are located in the United States and the catalogue segment was located in British Columbia, Canada. The e’commerce and catalogue segments were acquired in fiscal 2000. The Company discontinued its catalogue segment in 2002 and its e-commerce segment in 2003 (note 5). Consequently, all earned revenue and assets are now held in the United States. Segmented information for the years ended February 28, 2003, 2002 and 2001 for the Company’s continuing operating segments is as follows:
 
    Operating segments:

                         
    Healthcare   Call Centre        
2003   segment   segment   Total

 
 
 
Gross revenue
  $ 2,354,631     $ 1,249,802     $ 3,604,433  
 
   
     
     
 
Segment loss (income)
  $ 852,094     $ (53,509 )   $ 798,585  
Corporate
                1,366,402  
 
   
     
     
 
Loss from continuing operations
  $ 852,094     $ (53,509 )   $ 2,164,987  
 
   
     
     
 
Segment assets
  $ 4,755,717     $ 353,030     $ 5,108,747  
Corporate assets
                55,272  
Assets of discontinued operations (note 7)
                 
 
   
     
     
 
Total assets
  $ 4,755,717     $ 353,030     $ 5,164,019  
 
   
     
     
 

F-22


Table of Contents

12.   Segmented information (continued):
 
    Operating segments (continued):

                           
      Healthcare   Call Centre        
2003   segment   segment   Total

 
 
 
Equipment additions:
                       
 
Equipment
  $ 29,293     $ 5,075     $ 34,368  
 
Corporate
                1,115  
 
Discontinued operations
                577  
 
   
     
     
 
 
  $ 29,293     $ 5,075     $ 36,060  
 
   
     
     
 
Amortization expense
                       
 
Equipment
  $ 75,416     $ 40,582     $ 115,998  
 
Intellectual property
    1,209,764             1,209,764  
 
Corporate assets
                68,226  
 
   
     
     
 
 
  $ 1,285,180     $ 40,582     $ 1,393,988  
 
   
     
     
 
                           
      Healthcare   Call Centre        
2002   segment   segment   Total

 
 
 
Gross revenue
  $ 1,550,653     $ 1,229,819     $ 2,780,472  
 
   
     
     
 
Segment loss
  $ 936,759     $ 205,218     $ 1,141,977  
Corporate
                2,500,199  
 
   
     
     
 
Loss from continuing operations
  $ 936,759     $ 205,218     $ 3,642,176  
 
   
     
     
 
Segment assets
  $ 5,710,725     $ 272,891     $ 5,983,616  
Corporate assets
                965,645  
Assets of discontinued operations (note 5)
                259,604  
 
   
     
     
 
Total assets
  $ 5,710,725     $ 272,891     $ 7,208,865  
 
   
     
     
 
Equipment additions:
                       
 
Equipment
  $ 31,870     $ 49,737     $ 81,607  
 
Corporate
                10,641  
 
Discontinued operations
                30,461  
 
   
     
     
 
 
  $ 31,870     $ 49,737     $ 122,709  
 
   
     
     
 
Amortization expense
                       
 
Equipment
  $ 10,318     $ 43,159     $ 53,477  
 
Intellectual property
    705,695             705,695  
 
Corporate assets
                84,684  
 
   
     
     
 
 
  $ 716,013     $ 43,159     $ 843,856  
 
   
     
     
 

F-23


Table of Contents

12.   Segmented information (continued):
 
    Operating segments (continued):

                           
      Healthcare   Call Centre        
2001   segment   segment   Total

 
 
 
Gross revenue
  $     $ 770,153     $ 770,153  
 
   
     
     
 
Segment loss
  $     $ 169,729     $ 169,729  
Corporate
                2,672,174  
 
   
     
     
 
Loss from continuing operations
  $     $ 169,729     $ 2,841,903  
 
   
     
     
 
Segment assets
  $     $ 314,273     $ 314,273  
Corporate assets
                3,140,689  
Assets of discontinued operations
                2,813,271  
 
   
     
     
 
Total assets
  $     $ 314,273     $ 6,268,233  
 
   
     
     
 
Equipment additions:
                       
 
Equipment
  $     $ 134,175     $ 134,175  
 
Corporate
                4,833  
 
Discontinued operations
                922,607  
 
   
     
     
 
 
  $     $ 134,175     $ 1,061,615  
 
   
     
     
 
Amortization expense:
                       
 
Equipment
  $     $ 31,162     $ 31,162  
 
Corporate assets
                5,779  
 
   
     
     
 
 
  $     $ 31,162     $ 36,941  
 
   
     
     
 

Revenue:

                           
      2003   2002   2001
     
 
 
Call Centre service
  $ 1,148,802     $ 1,229,819     $ 770,153  
Healthcare:
                       
 
Book sales
    400,000       398,509        
 
Program revenues
    2,055,631       1,152,144        
 
   
     
     
 
 
  $ 3,604,433     $ 2,780,472     $ 770,153  
 
   
     
     
 

F-24


Table of Contents

13.   Major customers:
 
    Four major customers accounted for 60% (2002 — 56%) of total sales for the healthcare segment for the period ended February 28, 2003.
 
14.   Related party transactions:

  (a)   Payments totalling nil were made to the President and Concept 10 Inc., a company controlled by the President, during the year ended February 28, 2003 (2002 - $7,000; 2001 — $475,650) for services rendered in connection with a private placement of common shares.
 
  (b)   The Company had a licensing agreement with Queensland Teachers Union Health Fund Limited (“QTUH”) for a term of 20 years expiring April 30, 2019 to grant QTUH a license to use the Healthtrac Program in exchange for a monthly royalty calculated as $1 per questionnaire prepared in each calendar year. QTUH was also required to pay annual maintenance fees of $16,000 to the Company. The maintenance fees had not been accrued for the year ended February 28, 2002. In addition, QTUH’s royalty payments to the Company were suspended for the next five years expiring December 31, 2006.
 
      On the date of acquisition of Healthtrac, August 3, 2001, an amended license agreement was signed between QTUH and the Company. On that date, QTUH also signed a loan agreement in which QTUH agreed to provide a loan facility to the Company for a maximum of $110,000 at an interest rate of 1% over Bank of America’s prime rate. At February 28, 2002, $50,000 had been advanced to the Company under the arrangements (note 8) and a further $60,000 was advanced in fiscal 2003. QTUH had the right to convert the amount borrowed under the agreement into shares of the Company which is exercisable on the repayment date, being January 29, 2003. The number of shares to be issued would have been the amount of the loan on the date of election divided by the ten day average price per share for the Company’s common shares for the period ending on the date of conversion. In addition to the loan, the Company also owed QTUH $161,000 in accounts payable for prior book purchases funded by QTUH.
 
      On February 14, 2003, the Company and QTUH signed an amended license agreement that cancelled all the previous arrangements. Under the agreement, QTUH agreed to forgive the $110,000 loan amount and $161,000 in accounts payable in return for Healthtrac forgiving any amounts owed by QTUH to Healthtrac for maintenance fees, royalty payments and any other fees. In addition, QTUH and the Company agreed to grant QTUH a license to use the Healthtrac Program in various countries around the world for a term of 18 years expiring April 30, 2001 for a fee of $90,000. The Company has no ongoing requirements under this agreement and any additional services provided by the Company to QTUH are to be negotiated based on current market prices. As a result, the Company recognized the $90,000 in revenue in fiscal 2003.

F-25


Table of Contents

15.   Non-cash transactions and supplemental disclosures:
 
    The Company had the following material non-cash transactions:

                           
      2003   2002   2001
     
 
 
Non-cash transactions:
                       
 
Acquisition of equipment under capital lease
  $     $     $ 107,099  
Issuance of shares for:
                       
 
Employee and director compensation
    80,000       566,000       754,950  
 
Acquisition of Sullivan Park, LLC
                375,000  
 
Acquisition of fixed assets
                39,000  
 
Settlement of debt
    59,765       1,039,345       19,344  
 
Services received
    45,500       123,658       6,000  
 
Acquisition of MedWire assets (note 4(a))
          150,000        
 
Acquisition of Healthtrac, Inc. (note 3)
    107,588       4,600,000        
 
Acquisition of Healthscape, Inc. assets (note 4(b))
          240,000        
 
Severance payment
          100,000        
       
     
     

    Interest of $30,000 (2002 — $8,550; 2001 — $8,913) was paid in the year. No income taxes were paid in the years presented.
 
16.   Commitments and contingencies:

  (a)   Operating leases:
 
      The Company is committed to annual office and equipment rental payments for the next four years as follows:

         
2004
  $ 239,300  
2005
    220,911  
2006
    224,308  
2007
    118,195  
 
   
 
 
  $ 802,714  
 
   
 

  (c)   Legal proceedings:

         
    (i)   Rolling Meadows Premises:
         
        The Company moved its e’commerce operations from Rolling Meadows, Illinois to the Greenwood, Indiana offices during 2002. A complaint was filed for rent and damages in the amount of $859,512. The Company’s position on this proceeding is that the building has been sublet and deny that they owe the Plaintiff any money. The outcome of this complaint is currently uncertain.

F-26


Table of Contents

16.   Commitments and contingencies (continued):

  (c)   Legal proceedings (continued):

         
    (ii)   Vancouver Telephone Company Limited:
         
        On July 17, 2001 the Company reached a settlement for a lawsuit against one of its former customers. The settlement grants the Company CDN$275,000 to be received in various payments over eight months, with final payment on February 1, 2002. The Company recognized the funds upon receipt.
         
    (iii)   Other Litigation:
         
        The Company is involved in other legal proceedings and claims arising in the ordinary course of business including claims for outstanding payments for goods and services received and taxation claims. The Company does not believe than any liabilities related to the proceedings to which its is a party are likely to be, individually or in the aggregate, material to the Company’s consolidated financial condition, operations or cash flows. The Company has accrued for any amounts it considers likely in the consolidated financial statements.

17.   Reconciliation of United States to Canadian generally accepted accounting principles (“GAAP”):
 
    These financial statements are prepared in accordance with U.S. GAAP, the measurement principles of which do not differ materially from Canadian GAAP with respect to the accounting policies and disclosures in these financial statements, except as described in the following paragraph:
 
    Under U.S. GAAP, a reduction in an accumulated deficit with a corresponding reduction in common share stated capital is only permitted in limited circumstances. Under Canadian GAAP, a reduction in an accumulated deficit with a corresponding reduction in common share stated capital is permitted if approved by the shareholders of the Company. On August 22, 1996, the shareholders of the Company passed a special resolution to reduce the stated capital of the Company’s common shares by $86,729,000 (CDN — $117,535,000). As a result, under Canadian GAAP, common stock and accumulated deficit would each be reduced by $86,729,000 for all years presented.
 
18.   Comparative figures:
 
    Certain prior year figures have been reclassified to conform to the current year’s financial statement classification.

F-27


Table of Contents

HEALTHTRAC, INC.
Consolidated Schedule of Selling, General and Administrative Expenses
(Expressed in United States dollars)

                           
      Year ended   Year ended   Year ended
      February 28, 2003   February 28, 2002   February 29, 2001
     
 
 
              (Restated – note 5)   (Restated – note 5)
Wages and benefits:
                       
 
Cash and accrued
  $ 1,834,603     $ 1,564,205     $ 1,118,355  
 
Non-cash
    80,000       266,000       754,950  
Bad debts (recovery)
    (5,708 )     136,894       19,344  
Rent, utilities and property taxes
    352,954       282,117       162,481  
Consulting fees
    185,692       911,829       177,444  
Accounting and legal
    199,330       531,766       193,156  
Office and sundry
    140,683       330,390       219,710  
Marketing and advertising
    43,321       278,902       414,143  
Travel and promotion
    109,143       229,482       137,264  
Insurance
    229,214       177,339       100,872  
Telephone
    159,540       148,304       105,027  
Printing
    102,945       134,338       62,314  
Equipment rental
    58,117       60,986       3,457  
Bank charges and interest
    60,021       35,169       24,272  
Automobile
    8,092       20,907       18,860  
Recruiting
    751       323       7,430  
Licences, taxes and dues
    12,184       16,930       70  
Billing system fees
    7,894       17,794       44,878  
Subscriptions and dues
    1,287       3,138       5,634  
 
 
   
     
     
 
 
  $ 3,580,063     $ 5,146,813     $ 3,569,661  
 
 
   
     
     
 

F-28


Table of Contents

Exhibit Index

     
Exhibit    
Number   Description

 
99.1   Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 – Walter W. Straub, President, Chief Executive Officer and Chairman of the Board and Patrick E. Fevery, Vice President and Chief Financial Officer.

F-29